Frequencies for first 10,000 rows of pt variable in reac2006q4 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- 17-HYDROXYPROGESTERONE INCREASED | 1 0.01 0.01 ABASIA | 9 0.09 0.10 ABDOMINAL ABSCESS | 1 0.01 0.11 ABDOMINAL DISCOMFORT | 1 0.01 0.12 ABDOMINAL DISTENSION | 13 0.13 0.25 ABDOMINAL HERNIA | 1 0.01 0.26 ABDOMINAL MASS | 1 0.01 0.27 ABDOMINAL PAIN | 41 0.41 0.68 ABDOMINAL PAIN LOWER | 2 0.02 0.70 ABDOMINAL PAIN UPPER | 21 0.21 0.91 ABDOMINAL TENDERNESS | 3 0.03 0.94 ABDOMINAL WALL CYST | 1 0.01 0.95 ABDOMINOPLASTY | 1 0.01 0.96 ABNORMAL BEHAVIOUR | 10 0.10 1.06 ABNORMAL DREAMS | 3 0.03 1.09 ABNORMAL FAECES | 2 0.02 1.11 ABO HAEMOLYTIC DISEASE OF NEWBORN | 1 0.01 1.12 ABORTION | 1 0.01 1.13 ABORTION INDUCED | 2 0.02 1.15 ABORTION MISSED | 1 0.01 1.16 ABORTION SPONTANEOUS | 11 0.11 1.27 ABSCESS | 3 0.03 1.30 ABSCESS INTESTINAL | 2 0.02 1.32 ABULIA | 1 0.01 1.33 ACCIDENT | 1 0.01 1.34 ACCIDENTAL DEATH | 2 0.02 1.36 ACCIDENTAL EXPOSURE | 1 0.01 1.37 ACCIDENTAL OVERDOSE | 5 0.05 1.42 ACIDOSIS | 1 0.01 1.43 ACINETOBACTER BACTERAEMIA | 1 0.01 1.44 ACINETOBACTER INFECTION | 1 0.01 1.45 ACNE | 4 0.04 1.49 ACQUIRED DIAPHRAGMATIC EVENTRATION | 1 0.01 1.50 ACROMEGALY | 1 0.01 1.51 ACTINIC KERATOSIS | 1 0.01 1.52 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 7 0.07 1.59 ACTIVITIES OF DAILY LIVING IMPAIRED | 3 0.03 1.62 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 1 0.01 1.63 ACUTE HAEMORRHAGIC LEUKOENCEPHALITIS | 1 0.01 1.64 ACUTE MYELOID LEUKAEMIA | 11 0.11 1.75 ACUTE MYOCARDIAL INFARCTION | 4 0.04 1.79 ACUTE PRERENAL FAILURE | 1 0.01 1.80 ACUTE PULMONARY OEDEMA | 3 0.03 1.83 ACUTE RESPIRATORY DISTRESS SYNDROME | 9 0.09 1.92 ACUTE RESPIRATORY FAILURE | 2 0.02 1.94 ADDISON'S DISEASE | 1 0.01 1.95 ADENOCARCINOMA | 2 0.02 1.97 ADENOMA BENIGN | 1 0.01 1.98 ADENOVIRAL HAEMORRHAGIC CYSTITIS | 1 0.01 1.99 ADENOVIRUS INFECTION | 2 0.02 2.01 ADJUSTMENT DISORDER | 1 0.01 2.02 ADRENAL DISORDER | 1 0.01 2.03 ADRENAL INSUFFICIENCY | 3 0.03 2.06 ADRENOGENITAL SYNDROME | 1 0.01 2.07 ADVERSE DRUG REACTION | 4 0.04 2.11 ADVERSE EVENT | 2 0.02 2.13 AFFECT LABILITY | 1 0.01 2.14 AFFECTIVE DISORDER | 1 0.01 2.15 AGEUSIA | 2 0.02 2.17 AGGRESSION | 11 0.11 2.28 AGITATION | 22 0.22 2.50 AGITATION NEONATAL | 2 0.02 2.52 AGRANULOCYTOSIS | 3 0.03 2.55 AGRAPHIA | 1 0.01 2.56 AKATHISIA | 1 0.01 2.57 AKINESIA | 1 0.01 2.58 ALANINE AMINOTRANSFERASE DECREASED | 1 0.01 2.59 ALANINE AMINOTRANSFERASE INCREASED | 39 0.39 2.98 ALCOHOL INTOLERANCE | 1 0.01 2.99 ALCOHOL POISONING | 1 0.01 3.00 ALCOHOL USE | 6 0.06 3.06 ALCOHOLIC LIVER DISEASE | 1 0.01 3.07 ALCOHOLISM | 2 0.02 3.09 ALLERGIC COLITIS | 1 0.01 3.10 ALLERGIC GRANULOMATOUS ANGIITIS | 3 0.03 3.13 ALOPECIA | 11 0.11 3.24 ALOPECIA AREATA | 1 0.01 3.25 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 3.26 ALPORT'S SYNDROME | 1 0.01 3.27 ALVEOLAR PROTEINOSIS | 2 0.02 3.29 ALVEOLITIS ALLERGIC | 1 0.01 3.30 AMENORRHOEA | 3 0.03 3.33 AMMONIA INCREASED | 1 0.01 3.34 AMNESIA | 14 0.14 3.48 AMOEBIC DYSENTERY | 1 0.01 3.49 ANAEMIA | 43 0.43 3.92 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 3.93 ANAEMIA MACROCYTIC | 1 0.01 3.94 ANAEMIA OF CHRONIC DISEASE | 1 0.01 3.95 ANAEMIA OF MALIGNANT DISEASE | 1 0.01 3.96 ANAESTHETIC COMPLICATION | 1 0.01 3.97 ANAL FISSURE | 4 0.04 4.01 ANAL HAEMORRHAGE | 2 0.02 4.03 ANAL SKIN TAGS | 1 0.01 4.04 ANAL ULCER | 2 0.02 4.06 ANAPHYLACTIC REACTION | 12 0.12 4.18 ANAPHYLACTIC SHOCK | 10 0.10 4.28 ANAPHYLACTOID SHOCK | 1 0.01 4.29 ANEURYSM | 4 0.04 4.33 ANGER | 4 0.04 4.37 ANGINA PECTORIS | 6 0.06 4.43 ANGINA UNSTABLE | 3 0.03 4.46 ANGIONEUROTIC OEDEMA | 5 0.05 4.51 ANGIOPATHY | 1 0.01 4.52 ANGLE CLOSURE GLAUCOMA | 1 0.01 4.53 ANHEDONIA | 5 0.05 4.58 ANKLE FRACTURE | 1 0.01 4.59 ANKYLOGLOSSIA CONGENITAL | 1 0.01 4.60 ANOGENITAL WARTS | 1 0.01 4.61 ANOREXIA | 33 0.33 4.94 ANOSMIA | 3 0.03 4.97 ANOXIC ENCEPHALOPATHY | 2 0.02 4.99 ANTEPARTUM HAEMORRHAGE | 1 0.01 5.00 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 2 0.02 5.02 ANTI-INSULIN ANTIBODY | 1 0.01 5.03 ANTI-INSULIN ANTIBODY POSITIVE | 2 0.02 5.05 ANTICHOLINERGIC SYNDROME | 2 0.02 5.07 ANTICOAGULATION DRUG LEVEL ABOVE THER.. | 2 0.02 5.09 ANTICONVULSANT DRUG LEVEL | 2 0.02 5.11 ANTIDEPRESSANT DRUG LEVEL INCREASED | 1 0.01 5.12 ANTINUCLEAR ANTIBODY POSITIVE | 1 0.01 5.13 ANTIPHOSPHOLIPID SYNDROME | 2 0.02 5.15 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 1 0.01 5.16 ANTISOCIAL PERSONALITY DISORDER | 1 0.01 5.17 ANURIA | 6 0.06 5.23 ANXIETY | 35 0.35 5.58 AORTIC ANEURYSM | 1 0.01 5.59 AORTIC ARTERIOSCLEROSIS | 1 0.01 5.60 AORTIC VALVE DISEASE | 1 0.01 5.61 AORTIC VALVE INCOMPETENCE | 3 0.03 5.64 AORTIC VALVE STENOSIS | 1 0.01 5.65 APALLIC SYNDROME | 1 0.01 5.66 APATHY | 1 0.01 5.67 APGAR SCORE LOW | 2 0.02 5.69 APHASIA | 4 0.04 5.73 APHONIA | 2 0.02 5.75 APHTHOUS STOMATITIS | 6 0.06 5.81 APLASIA | 2 0.02 5.83 APLASIA PURE RED CELL | 6 0.06 5.89 APLASTIC ANAEMIA | 1 0.01 5.90 APNOEA | 3 0.03 5.93 APNOEIC ATTACK | 1 0.01 5.94 APPENDICITIS | 2 0.02 5.96 APPENDICITIS PERFORATED | 1 0.01 5.97 APPLICATION SITE BRUISING | 1 0.01 5.98 APPLICATION SITE BURN | 1 0.01 5.99 APPLICATION SITE DERMATITIS | 3 0.03 6.02 APPLICATION SITE DISCOLOURATION | 1 0.01 6.03 APPLICATION SITE ERYTHEMA | 4 0.04 6.07 APPLICATION SITE INFECTION | 1 0.01 6.08 APPLICATION SITE IRRITATION | 3 0.03 6.11 APPLICATION SITE OEDEMA | 1 0.01 6.12 APPLICATION SITE PAIN | 1 0.01 6.13 APPLICATION SITE PRURITUS | 2 0.02 6.15 APPLICATION SITE REACTION | 2 0.02 6.17 AREFLEXIA | 3 0.03 6.20 ARRHYTHMIA | 15 0.15 6.35 ARRHYTHMIA SUPRAVENTRICULAR | 1 0.01 6.36 ARTERIAL DISORDER | 1 0.01 6.37 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 6.38 ARTERIAL RUPTURE | 1 0.01 6.39 ARTERIAL THERAPEUTIC PROCEDURE | 1 0.01 6.40 ARTERIAL THROMBOSIS LIMB | 3 0.03 6.43 ARTERIOSCLEROSIS | 2 0.02 6.45 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 6.46 ARTERIOSPASM CORONARY | 1 0.01 6.47 ARTERIOVENOUS FISTULA | 1 0.01 6.48 ARTERIOVENOUS MALFORMATION | 1 0.01 6.49 ARTHRALGIA | 39 0.39 6.88 ARTHRITIS | 8 0.08 6.96 ARTHRITIS BACTERIAL | 1 0.01 6.97 ARTHRITIS ENTEROPATHIC | 1 0.01 6.98 ARTHRITIS INFECTIVE | 1 0.01 6.99 ARTHRITIS REACTIVE | 1 0.01 7.00 ARTHROFIBROSIS | 1 0.01 7.01 ARTHROPATHY | 3 0.03 7.04 ASCITES | 11 0.11 7.15 ASPARTATE AMINOTRANSFERASE INCREASED | 35 0.35 7.50 ASPERGILLOSIS | 2 0.02 7.52 ASPHYXIA | 2 0.02 7.54 ASPIRATION | 5 0.05 7.59 ASPIRATION BONE MARROW | 1 0.01 7.60 ASPIRATION BONE MARROW ABNORMAL | 1 0.01 7.61 ASPIRATION BRONCHIAL | 1 0.01 7.62 ASTHENIA | 69 0.69 8.31 ASTHENOPIA | 1 0.01 8.32 ASTHMA | 8 0.08 8.40 ASTHMATIC CRISIS | 1 0.01 8.41 ATELECTASIS | 4 0.04 8.45 ATLANTOAXIAL INSTABILITY | 1 0.01 8.46 ATRIAL FIBRILLATION | 20 0.20 8.66 ATRIAL FLUTTER | 3 0.03 8.69 ATRIAL SEPTAL DEFECT | 4 0.04 8.73 ATRIOVENTRICULAR BLOCK | 2 0.02 8.75 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 8.76 ATRIOVENTRICULAR BLOCK THIRD DEGREE | 3 0.03 8.79 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 1 0.01 8.80 AURICULAR SWELLING | 1 0.01 8.81 AUTISM | 4 0.04 8.85 AUTOIMMUNE DISORDER | 4 0.04 8.89 AUTOIMMUNE HEPATITIS | 1 0.01 8.90 AV DISSOCIATION | 1 0.01 8.91 AZOOSPERMIA | 1 0.01 8.92 AZOTAEMIA | 4 0.04 8.96 B-CELL LYMPHOMA | 1 0.01 8.97 BACILLUS INFECTION | 1 0.01 8.98 BACK DISORDER | 1 0.01 8.99 BACK PAIN | 50 0.50 9.49 BACTERAEMIA | 3 0.03 9.52 BACTERIA BLOOD IDENTIFIED | 2 0.02 9.54 BACTERIA BODY FLUID IDENTIFIED | 1 0.01 9.55 BACTERIA SPUTUM IDENTIFIED | 1 0.01 9.56 BACTERIA STOOL IDENTIFIED | 1 0.01 9.57 BACTERIAL INFECTION | 7 0.07 9.64 BACTERIAL TOXAEMIA | 2 0.02 9.66 BACTERIURIA | 1 0.01 9.67 BACTEROIDES INFECTION | 2 0.02 9.69 BALANCE DISORDER | 11 0.11 9.80 BAND NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 9.81 BARRETT'S OESOPHAGUS | 1 0.01 9.82 BASAL CELL CARCINOMA | 1 0.01 9.83 BASEDOW'S DISEASE | 1 0.01 9.84 BEDRIDDEN | 1 0.01 9.85 BELLIGERENCE | 1 0.01 9.86 BENIGN HYDATIDIFORM MOLE | 1 0.01 9.87 BENIGN PROSTATIC HYPERPLASIA | 1 0.01 9.88 BETA 2 MICROGLOBULIN INCREASED | 1 0.01 9.89 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 1 0.01 9.90 BETA-N-ACETYL-D-GLUCOSAMINIDASE INCRE.. | 1 0.01 9.91 BILE DUCT STENOSIS | 1 0.01 9.92 BILE DUCT STONE | 1 0.01 9.93 BILIARY ADENOMA | 1 0.01 9.94 BILIARY CYST | 1 0.01 9.95 BILIARY TRACT DISORDER | 1 0.01 9.96 BIOPSY LIVER | 1 0.01 9.97 BIOPSY LIVER ABNORMAL | 1 0.01 9.98 BIPOLAR DISORDER | 1 0.01 9.99 BLADDER CANCER | 6 0.06 10.05 BLADDER SPASM | 1 0.01 10.06 BLADDER TAMPONADE | 1 0.01 10.07 BLAST CELL COUNT INCREASED | 1 0.01 10.08 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 10.09 BLEPHARITIS | 2 0.02 10.11 BLINDNESS | 14 0.14 10.25 BLINDNESS TRANSIENT | 5 0.05 10.30 BLINDNESS UNILATERAL | 8 0.08 10.38 BLISTER | 10 0.10 10.48 BLOOD ALBUMIN DECREASED | 7 0.07 10.55 BLOOD ALKALINE PHOSPHATASE INCREASED | 16 0.16 10.71 BLOOD AMYLASE INCREASED | 4 0.04 10.75 BLOOD BETA-D-GLUCAN INCREASED | 1 0.01 10.76 BLOOD BICARBONATE DECREASED | 2 0.02 10.78 BLOOD BILIRUBIN | 1 0.01 10.79 BLOOD BILIRUBIN ABNORMAL | 1 0.01 10.80 BLOOD BILIRUBIN INCREASED | 14 0.14 10.94 BLOOD CALCIUM DECREASED | 2 0.02 10.96 BLOOD CALCIUM INCREASED | 4 0.04 11.00 BLOOD CHLORIDE DECREASED | 2 0.02 11.02 BLOOD CHLORIDE INCREASED | 2 0.02 11.04 BLOOD CHOLESTEROL ABNORMAL | 3 0.03 11.07 BLOOD CHOLESTEROL INCREASED | 7 0.07 11.14 BLOOD CORTICOTROPHIN INCREASED | 1 0.01 11.15 BLOOD COUNT ABNORMAL | 1 0.01 11.16 BLOOD CREATINE PHOSPHOKINASE INCREASED | 31 0.31 11.47 BLOOD CREATINE PHOSPHOKINASE MB ABNOR.. | 1 0.01 11.48 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 2 0.02 11.50 BLOOD CREATININE INCREASED | 31 0.31 11.81 BLOOD CULTURE POSITIVE | 1 0.01 11.82 BLOOD DISORDER | 1 0.01 11.83 BLOOD FIBRINOGEN INCREASED | 2 0.02 11.85 BLOOD GASES ABNORMAL | 2 0.02 11.87 BLOOD GLUCOSE ABNORMAL | 1 0.01 11.88 BLOOD GLUCOSE DECREASED | 10 0.10 11.98 BLOOD GLUCOSE FLUCTUATION | 4 0.04 12.02 BLOOD GLUCOSE INCREASED | 29 0.29 12.31 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 1 0.01 12.32 BLOOD IMMUNOGLOBULIN E INCREASED | 2 0.02 12.34 BLOOD IMMUNOGLOBULIN G | 1 0.01 12.35 BLOOD LACTATE DEHYDROGENASE INCREASED | 16 0.16 12.51 BLOOD LACTIC ACID INCREASED | 1 0.01 12.52 BLOOD MAGNESIUM DECREASED | 1 0.01 12.53 BLOOD OESTROGEN ABNORMAL | 1 0.01 12.54 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 12.55 BLOOD PH DECREASED | 2 0.02 12.57 BLOOD PHOSPHORUS DECREASED | 2 0.02 12.59 BLOOD POTASSIUM DECREASED | 12 0.12 12.71 BLOOD POTASSIUM INCREASED | 12 0.12 12.83 BLOOD PRESSURE ABNORMAL | 4 0.04 12.87 BLOOD PRESSURE DECREASED | 17 0.17 13.04 BLOOD PRESSURE DIASTOLIC DECREASED | 2 0.02 13.06 BLOOD PRESSURE FLUCTUATION | 1 0.01 13.07 BLOOD PRESSURE IMMEASURABLE | 2 0.02 13.09 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 13.10 BLOOD PRESSURE INCREASED | 43 0.43 13.53 BLOOD PRESSURE ORTHOSTATIC | 1 0.01 13.54 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 13.55 BLOOD PRESSURE SYSTOLIC INCREASED | 4 0.04 13.59 BLOOD PROLACTIN INCREASED | 1 0.01 13.60 BLOOD SODIUM DECREASED | 9 0.09 13.69 BLOOD SODIUM INCREASED | 1 0.01 13.70 BLOOD TEST ABNORMAL | 2 0.02 13.72 BLOOD TESTOSTERONE DECREASED | 1 0.01 13.73 BLOOD THYROID STIMULATING HORMONE ABN.. | 1 0.01 13.74 BLOOD THYROID STIMULATING HORMONE DEC.. | 1 0.01 13.75 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 13.76 BLOOD TRIGLYCERIDES INCREASED | 11 0.11 13.87 BLOOD UREA DECREASED | 1 0.01 13.88 BLOOD UREA INCREASED | 20 0.20 14.08 BLOOD UREA NITROGEN/CREATININE RATIO .. | 1 0.01 14.09 BLOOD URIC ACID INCREASED | 2 0.02 14.11 BLOOD URINE PRESENT | 2 0.02 14.13 BLOOD ZINC DECREASED | 1 0.01 14.14 BODY TEMPERATURE DECREASED | 1 0.01 14.15 BODY TEMPERATURE INCREASED | 4 0.04 14.19 BONE CYST | 1 0.01 14.20 BONE DENSITY DECREASED | 2 0.02 14.22 BONE DISORDER | 9 0.09 14.31 BONE EROSION | 2 0.02 14.33 BONE LESION | 1 0.01 14.34 BONE MARROW FAILURE | 16 0.16 14.50 BONE MARROW NECROSIS | 1 0.01 14.51 BONE MARROW TRANSPLANT | 2 0.02 14.53 BONE PAIN | 7 0.07 14.60 BONE SWELLING | 1 0.01 14.61 BONE TRIMMING | 1 0.01 14.62 BOVINE TUBERCULOSIS | 1 0.01 14.63 BRADYCARDIA | 8 0.08 14.71 BRADYCARDIA NEONATAL | 2 0.02 14.73 BRADYPHRENIA | 1 0.01 14.74 BRAIN DEATH | 1 0.01 14.75 BRAIN MASS | 1 0.01 14.76 BRAIN NATRIURETIC PEPTIDE INCREASED | 1 0.01 14.77 BRAIN NEOPLASM | 1 0.01 14.78 BRAIN OEDEMA | 5 0.05 14.83 BRAIN OPERATION | 2 0.02 14.85 BRAIN SCAN ABNORMAL | 1 0.01 14.86 BRAIN STEM INFARCTION | 2 0.02 14.88 BRAIN TUMOUR OPERATION | 1 0.01 14.89 BREAST CANCER | 10 0.10 14.99 BREAST CANCER FEMALE | 6 0.06 15.05 BREAST CANCER IN SITU | 2 0.02 15.07 BREAST CANCER MALE | 1 0.01 15.08 BREAST CANCER METASTATIC | 2 0.02 15.10 BREAST CANCER STAGE II | 1 0.01 15.11 BREAST DISORDER | 1 0.01 15.12 BREAST MASS | 2 0.02 15.14 BREAST TENDERNESS | 1 0.01 15.15 BREATH SOUNDS ABNORMAL | 4 0.04 15.19 BRONCHIAL OBSTRUCTION | 1 0.01 15.20 BRONCHIECTASIS | 2 0.02 15.22 BRONCHIOLITIS | 1 0.01 15.23 BRONCHITIS | 3 0.03 15.26 BRONCHITIS ACUTE | 3 0.03 15.29 BRONCHOALVEOLAR LAVAGE ABNORMAL | 1 0.01 15.30 BRONCHOPNEUMONIA | 3 0.03 15.33 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 15.34 BRONCHOSPASM | 6 0.06 15.40 BRUGADA SYNDROME | 1 0.01 15.41 BUDD-CHIARI SYNDROME | 1 0.01 15.42 BULBAR PALSY | 1 0.01 15.43 BULIMIA NERVOSA | 1 0.01 15.44 BUNDLE BRANCH BLOCK RIGHT | 3 0.03 15.47 BURNING SENSATION | 7 0.07 15.54 BUTTOCK PAIN | 1 0.01 15.55 C-REACTIVE PROTEIN INCREASED | 14 0.14 15.69 CAESAREAN SECTION | 8 0.08 15.77 CALCIFICATION PANCREATIC DUCT | 1 0.01 15.78 CALCINOSIS | 2 0.02 15.80 CALCULUS BLADDER | 1 0.01 15.81 CALCULUS URETERIC | 1 0.01 15.82 CANCER PAIN | 2 0.02 15.84 CANDIDA PNEUMONIA | 1 0.01 15.85 CANDIDA SEPSIS | 1 0.01 15.86 CANDIDIASIS | 6 0.06 15.92 CAPILLARY LEAK SYNDROME | 1 0.01 15.93 CARBOHYDRATE ANTIGEN 125 INCREASED | 1 0.01 15.94 CARBON DIOXIDE DECREASED | 1 0.01 15.95 CARBON MONOXIDE POISONING | 1 0.01 15.96 CARCINOEMBRYONIC ANTIGEN INCREASED | 1 0.01 15.97 CARDIAC ARREST | 18 0.18 16.15 CARDIAC DISORDER | 17 0.17 16.32 CARDIAC ENZYMES INCREASED | 1 0.01 16.33 CARDIAC FAILURE | 22 0.22 16.55 CARDIAC FAILURE CONGESTIVE | 23 0.23 16.78 CARDIAC FIBRILLATION | 1 0.01 16.79 CARDIAC FLUTTER | 1 0.01 16.80 CARDIAC HYPERTROPHY | 3 0.03 16.83 CARDIAC MURMUR | 4 0.04 16.87 CARDIAC PACEMAKER INSERTION | 2 0.02 16.89 CARDIAC PROCEDURE COMPLICATION | 1 0.01 16.90 CARDIAC VALVE DISEASE | 3 0.03 16.93 CARDIAC VALVE VEGETATION | 1 0.01 16.94 CARDIO-RESPIRATORY ARREST | 12 0.12 17.06 CARDIOACTIVE DRUG LEVEL INCREASED | 2 0.02 17.08 CARDIOGENIC SHOCK | 5 0.05 17.13 CARDIOMEGALY | 8 0.08 17.21 CARDIOMYOPATHY | 4 0.04 17.25 CARDIOPULMONARY FAILURE | 2 0.02 17.27 CARDIOVASCULAR DISORDER | 7 0.07 17.34 CARDIOVASCULAR INSUFFICIENCY | 2 0.02 17.36 CAROTID ARTERY ANEURYSM | 1 0.01 17.37 CAROTID ARTERY OCCLUSION | 1 0.01 17.38 CAROTID ARTERY STENOSIS | 2 0.02 17.40 CAROTID ARTERY THROMBOSIS | 1 0.01 17.41 CAROTID ENDARTERECTOMY | 1 0.01 17.42 CARPAL TUNNEL SYNDROME | 1 0.01 17.43 CARTILAGE INJURY | 1 0.01 17.44 CATARACT | 9 0.09 17.53 CATARACT OPERATION | 2 0.02 17.55 CATATONIA | 2 0.02 17.57 CATHETER PLACEMENT | 1 0.01 17.58 CATHETER RELATED COMPLICATION | 2 0.02 17.60 CATHETER RELATED INFECTION | 1 0.01 17.61 CATHETER SITE CELLULITIS | 1 0.01 17.62 CATHETER SITE HAEMORRHAGE | 1 0.01 17.63 CATHETER SITE INFECTION | 2 0.02 17.65 CAUDA EQUINA SYNDROME | 1 0.01 17.66 CD4 LYMPHOCYTES DECREASED | 1 0.01 17.67 CD4/CD8 RATIO INCREASED | 1 0.01 17.68 CELL MARKER INCREASED | 1 0.01 17.69 CELLULITIS | 8 0.08 17.77 CELLULITIS ORBITAL | 1 0.01 17.78 CELLULITIS STAPHYLOCOCCAL | 2 0.02 17.80 CENTRAL NERVOUS SYSTEM LESION | 3 0.03 17.83 CENTRAL NERVOUS SYSTEM NECROSIS | 1 0.01 17.84 CEREBELLAR INFARCTION | 2 0.02 17.86 CEREBRAL ATROPHY | 1 0.01 17.87 CEREBRAL DISORDER | 1 0.01 17.88 CEREBRAL HAEMORRHAGE | 8 0.08 17.96 CEREBRAL INFARCTION | 11 0.11 18.07 CEREBRAL ISCHAEMIA | 3 0.03 18.10 CEREBRAL PALSY | 2 0.02 18.12 CEREBRAL VENTRICLE DILATATION | 2 0.02 18.14 CEREBROVASCULAR ACCIDENT | 13 0.13 18.27 CEREBROVASCULAR DISORDER | 3 0.03 18.30 CERULOPLASMIN INCREASED | 1 0.01 18.31 CERVICAL SPINAL STENOSIS | 1 0.01 18.32 CHANGE OF BOWEL HABIT | 1 0.01 18.33 CHEILITIS | 1 0.01 18.34 CHEMOTHERAPY | 1 0.01 18.35 CHEST DISCOMFORT | 14 0.14 18.49 CHEST PAIN | 38 0.38 18.87 CHEST X-RAY ABNORMAL | 2 0.02 18.89 CHILD ABUSE | 1 0.01 18.90 CHILD MALTREATMENT SYNDROME | 2 0.02 18.92 CHILLS | 24 0.24 19.16 CHOKING | 2 0.02 19.18 CHOLANGITIS | 2 0.02 19.20 CHOLANGITIS ACUTE | 1 0.01 19.21 CHOLECYSTECTOMY | 1 0.01 19.22 CHOLECYSTITIS | 7 0.07 19.29 CHOLECYSTITIS ACUTE | 1 0.01 19.30 CHOLELITHIASIS | 6 0.06 19.36 CHOLESTASIS | 5 0.05 19.41 CHONDROLYSIS | 1 0.01 19.42 CHONDROSARCOMA | 1 0.01 19.43 CHORIOAMNIONITIS | 2 0.02 19.45 CHOROIDAL NEOVASCULARISATION | 1 0.01 19.46 CHROMATURIA | 8 0.08 19.54 CHROMOSOME ABNORMALITY | 2 0.02 19.56 CHRONIC FATIGUE SYNDROME | 3 0.03 19.59 CHRONIC MYELOID LEUKAEMIA | 4 0.04 19.63 CHRONIC MYELOMONOCYTIC LEUKAEMIA | 1 0.01 19.64 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 5 0.05 19.69 CHRONIC SINUSITIS | 1 0.01 19.70 CIRCULATING ANTICOAGULANT | 1 0.01 19.71 CIRCULATORY COLLAPSE | 6 0.06 19.77 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 19 0.19 19.96 CLAUSTROPHOBIA | 1 0.01 19.97 CLOSTRIDIAL INFECTION | 4 0.04 20.01 CLOSTRIDIUM DIFFICILE COLITIS | 1 0.01 20.02 CLUBBING | 1 0.01 20.03 COAGULATION TEST ABNORMAL | 1 0.01 20.04 COAGULATION TIME PROLONGED | 2 0.02 20.06 COAGULOPATHY | 5 0.05 20.11 COCCIDIOIDOMYCOSIS | 1 0.01 20.12 COELIAC DISEASE | 1 0.01 20.13 COGNITIVE DISORDER | 6 0.06 20.19 COLD AGGLUTININS POSITIVE | 1 0.01 20.20 COLD SWEAT | 4 0.04 20.24 COLITIS | 13 0.13 20.37 COLITIS ISCHAEMIC | 4 0.04 20.41 COLITIS ULCERATIVE | 8 0.08 20.49 COLLAGEN DISORDER | 1 0.01 20.50 COLON CANCER | 8 0.08 20.58 COLON INJURY | 1 0.01 20.59 COLONIC FISTULA | 1 0.01 20.60 COLONIC POLYP | 1 0.01 20.61 COLOSTOMY | 1 0.01 20.62 COLOUR BLINDNESS | 1 0.01 20.63 COMA | 16 0.16 20.79 COMA HEPATIC | 2 0.02 20.81 COMPLETED SUICIDE | 12 0.12 20.93 COMPLICATIONS OF TRANSPLANT SURGERY | 1 0.01 20.94 COMPLICATIONS OF TRANSPLANTED LIVER | 1 0.01 20.95 COMPRESSION FRACTURE | 1 0.01 20.96 COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL | 1 0.01 20.97 COMPUTERISED TOMOGRAM ABNORMAL | 7 0.07 21.04 CONCOMITANT DISEASE PROGRESSION | 1 0.01 21.05 CONDITION AGGRAVATED | 51 0.51 21.56 CONDUCTION DISORDER | 1 0.01 21.57 CONFUSIONAL STATE | 31 0.31 21.88 CONGENITAL ANOMALY | 4 0.04 21.92 CONGENITAL CORONARY ARTERY MALFORMATION | 1 0.01 21.93 CONGENITAL CYSTIC KIDNEY DISEASE | 1 0.01 21.94 CONGENITAL FOOT MALFORMATION | 1 0.01 21.95 CONGENITAL HYDRONEPHROSIS | 1 0.01 21.96 CONGENITAL MUSCULOSKELETAL ANOMALY | 1 0.01 21.97 CONJUNCTIVAL HAEMORRHAGE | 2 0.02 21.99 CONJUNCTIVITIS | 2 0.02 22.01 CONSTIPATION | 28 0.28 22.29 CONTRACEPTIVE DEVICE COMPLICATION | 1 0.01 22.30 CONTRACTED BLADDER | 1 0.01 22.31 CONTUSION | 11 0.11 22.42 CONVERSION DISORDER | 2 0.02 22.44 CONVULSION | 41 0.41 22.85 CONVULSION NEONATAL | 1 0.01 22.86 COOMBS TEST POSITIVE | 3 0.03 22.89 COORDINATION ABNORMAL | 13 0.13 23.02 CORNEAL ABRASION | 1 0.01 23.03 CORNEAL DEPOSITS | 1 0.01 23.04 CORONARY ARTERY ANEURYSM | 1 0.01 23.05 CORONARY ARTERY BYPASS | 2 0.02 23.07 CORONARY ARTERY DISEASE | 3 0.03 23.10 CORONARY ARTERY DISSECTION | 2 0.02 23.12 CORONARY ARTERY INSUFFICIENCY | 1 0.01 23.13 CORONARY ARTERY OCCLUSION | 4 0.04 23.17 CORONARY ARTERY STENOSIS | 1 0.01 23.18 COSTOCHONDRITIS | 1 0.01 23.19 COUGH | 27 0.27 23.46 COW'S MILK INTOLERANCE | 1 0.01 23.47 COXSACKIE VIRAL INFECTION | 1 0.01 23.48 CRANIOTOMY | 1 0.01 23.49 CREATININE RENAL CLEARANCE DECREASED | 2 0.02 23.51 CREPITATIONS | 1 0.01 23.52 CREUTZFELDT-JAKOB DISEASE | 1 0.01 23.53 CROHN'S DISEASE | 9 0.09 23.62 CRYING | 5 0.05 23.67 CRYPTOGENIC CIRRHOSIS | 1 0.01 23.68 CRYPTOGENIC ORGANISING PNEUMONIA | 1 0.01 23.69 CSF CELL COUNT INCREASED | 1 0.01 23.70 CSF PROTEIN INCREASED | 1 0.01 23.71 CYANOSIS | 11 0.11 23.82 CYANOSIS NEONATAL | 1 0.01 23.83 CYST | 2 0.02 23.85 CYSTITIS | 7 0.07 23.92 CYSTITIS INTERSTITIAL | 1 0.01 23.93 CYSTITIS RADIATION | 1 0.01 23.94 CYTOGENETIC ANALYSIS | 1 0.01 23.95 CYTOLYTIC HEPATITIS | 5 0.05 24.00 CYTOMEGALOVIRUS ANTIGEN POSITIVE | 2 0.02 24.02 CYTOMEGALOVIRUS INFECTION | 5 0.05 24.07 CYTOMEGALOVIRUS TEST POSITIVE | 1 0.01 24.08 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 24.09 DEAFNESS | 2 0.02 24.11 DEAFNESS BILATERAL | 3 0.03 24.14 DEAFNESS NEUROSENSORY | 2 0.02 24.16 DEAFNESS UNILATERAL | 1 0.01 24.17 DEATH | 44 0.44 24.61 DEATH NEONATAL | 3 0.03 24.64 DECREASED ACTIVITY | 2 0.02 24.66 DECREASED APPETITE | 8 0.08 24.74 DECREASED INTEREST | 1 0.01 24.75 DECUBITUS ULCER | 1 0.01 24.76 DEEP VEIN THROMBOSIS | 23 0.23 24.99 DEHYDRATION | 52 0.52 25.51 DEJA VU | 1 0.01 25.52 DELIRIUM | 10 0.10 25.62 DELUSION | 3 0.03 25.65 DEMENTIA | 4 0.04 25.69 DEMYELINATING POLYNEUROPATHY | 1 0.01 25.70 DEMYELINATION | 1 0.01 25.71 DENTAL CARIES | 3 0.03 25.74 DENTAL EXAMINATION ABNORMAL | 1 0.01 25.75 DENTAL IMPLANTATION | 1 0.01 25.76 DENTAL PROSTHESIS PLACEMENT | 1 0.01 25.77 DEPENDENCE | 4 0.04 25.81 DEPERSONALISATION | 1 0.01 25.82 DEPRESSED LEVEL OF CONSCIOUSNESS | 33 0.33 26.15 DEPRESSED MOOD | 6 0.06 26.21 DEPRESSION | 36 0.36 26.57 DEPRESSION SUICIDAL | 1 0.01 26.58 DEPRESSIVE SYMPTOM | 1 0.01 26.59 DERMATITIS | 2 0.02 26.61 DERMATITIS ACNEIFORM | 1 0.01 26.62 DERMATITIS ALLERGIC | 2 0.02 26.64 DERMATITIS BULLOUS | 1 0.01 26.65 DERMATITIS CONTACT | 3 0.03 26.68 DERMATITIS EXFOLIATIVE | 1 0.01 26.69 DEVELOPMENTAL DELAY | 2 0.02 26.71 DEVELOPMENTAL GLAUCOMA | 1 0.01 26.72 DEVICE BREAKAGE | 2 0.02 26.74 DEVICE FAILURE | 2 0.02 26.76 DEVICE LEAKAGE | 1 0.01 26.77 DEVICE RELATED INFECTION | 1 0.01 26.78 DIABETES INSIPIDUS | 1 0.01 26.79 DIABETES MELLITUS | 32 0.32 27.11 DIABETES MELLITUS INADEQUATE CONTROL | 7 0.07 27.18 DIABETES MELLITUS INSULIN-DEPENDENT | 4 0.04 27.22 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 2 0.02 27.24 DIABETIC COMA | 2 0.02 27.26 DIABETIC KETOACIDOSIS | 6 0.06 27.32 DIABETIC NEUROPATHY | 1 0.01 27.33 DIABETIC RETINOPATHY | 1 0.01 27.34 DIABETIC ULCER | 1 0.01 27.35 DIAGNOSTIC PROCEDURE | 1 0.01 27.36 DIALYSIS | 5 0.05 27.41 DIARRHOEA | 77 0.77 28.18 DIARRHOEA HAEMORRHAGIC | 4 0.04 28.22 DIET REFUSAL | 1 0.01 28.23 DIFFUSE LARGE B-CELL LYMPHOMA | 2 0.02 28.25 DIPLEGIA | 1 0.01 28.26 DIPLOPIA | 5 0.05 28.31 DISABLED RELATIVE | 1 0.01 28.32 DISCOMFORT | 4 0.04 28.36 DISEASE PROGRESSION | 25 0.25 28.61 DISEASE RECURRENCE | 10 0.10 28.71 DISINHIBITION | 1 0.01 28.72 DISORIENTATION | 14 0.14 28.86 DISSEMINATED INTRAVASCULAR COAGULATION | 17 0.17 29.03 DISSEMINATED TUBERCULOSIS | 1 0.01 29.04 DISTURBANCE IN ATTENTION | 11 0.11 29.15 DISTURBANCE IN SOCIAL BEHAVIOUR | 1 0.01 29.16 DIVERTICULAR PERFORATION | 1 0.01 29.17 DIVERTICULITIS | 7 0.07 29.24 DIVERTICULUM | 4 0.04 29.28 DIZZINESS | 76 0.76 30.04 DIZZINESS POSTURAL | 2 0.02 30.06 DOCUMENTED HYPERSENSITIVITY TO ADMINI.. | 1 0.01 30.07 DROOLING | 2 0.02 30.09 DROWNING | 1 0.01 30.10 DRUG ABUSER | 16 0.16 30.26 DRUG ADMINISTRATION ERROR | 8 0.08 30.34 DRUG CLEARANCE INCREASED | 1 0.01 30.35 DRUG DEPENDENCE | 8 0.08 30.43 DRUG DISPENSING ERROR | 27 0.27 30.70 DRUG DOSE OMISSION | 6 0.06 30.76 DRUG EFFECT DECREASED | 16 0.16 30.92 DRUG ERUPTION | 4 0.04 30.96 DRUG EXPOSURE BEFORE PREGNANCY | 4 0.04 31.00 DRUG EXPOSURE DURING PREGNANCY | 60 0.60 31.60 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 31.61 DRUG HYPERSENSITIVITY | 15 0.15 31.76 DRUG INEFFECTIVE | 77 0.77 32.53 DRUG INTERACTION | 27 0.27 32.80 DRUG INTERACTION POTENTIATION | 1 0.01 32.81 DRUG INTOLERANCE | 5 0.05 32.86 DRUG LEVEL BELOW THERAPEUTIC | 2 0.02 32.88 DRUG LEVEL CHANGED | 1 0.01 32.89 DRUG LEVEL DECREASED | 1 0.01 32.90 DRUG LEVEL INCREASED | 3 0.03 32.93 DRUG PRESCRIBING ERROR | 6 0.06 32.99 DRUG RESISTANCE | 6 0.06 33.05 DRUG SCREEN POSITIVE | 6 0.06 33.11 DRUG TOLERANCE | 1 0.01 33.12 DRUG TOLERANCE DECREASED | 1 0.01 33.13 DRUG TOXICITY | 21 0.21 33.34 DRUG WITHDRAWAL SYNDROME | 19 0.19 33.53 DRUG WITHDRAWAL SYNDROME NEONATAL | 1 0.01 33.54 DRY EYE | 1 0.01 33.55 DRY MOUTH | 7 0.07 33.62 DRY SKIN | 12 0.12 33.74 DRY THROAT | 2 0.02 33.76 DUODENAL ULCER | 3 0.03 33.79 DUODENITIS | 2 0.02 33.81 DYSAESTHESIA | 1 0.01 33.82 DYSARTHRIA | 11 0.11 33.93 DYSCALCULIA | 1 0.01 33.94 DYSGEUSIA | 7 0.07 34.01 DYSGRAPHIA | 2 0.02 34.03 DYSKINESIA | 11 0.11 34.14 DYSKINESIA OESOPHAGEAL | 1 0.01 34.15 DYSLALIA | 1 0.01 34.16 DYSMENORRHOEA | 1 0.01 34.17 DYSPEPSIA | 11 0.11 34.28 DYSPHAGIA | 21 0.21 34.49 DYSPHASIA | 2 0.02 34.51 DYSPHONIA | 6 0.06 34.57 DYSPLASTIC NAEVUS SYNDROME | 1 0.01 34.58 DYSPNOEA | 98 0.98 35.56 DYSPNOEA EXERTIONAL | 7 0.07 35.63 DYSPRAXIA | 1 0.01 35.64 DYSSTASIA | 3 0.03 35.67 DYSTHYMIC DISORDER | 1 0.01 35.68 DYSTONIA | 3 0.03 35.71 DYSURIA | 4 0.04 35.75 EAR DISCOMFORT | 2 0.02 35.77 EAR HAEMORRHAGE | 1 0.01 35.78 EAR INFECTION | 5 0.05 35.83 EAR PAIN | 4 0.04 35.87 EAR PRURITUS | 1 0.01 35.88 EARLY SATIETY | 1 0.01 35.89 EATING DISORDER | 6 0.06 35.95 ECCHYMOSIS | 4 0.04 35.99 ECONOMIC PROBLEM | 1 0.01 36.00 ECZEMA | 5 0.05 36.05 EDUCATIONAL PROBLEM | 2 0.02 36.07 EFFUSION | 2 0.02 36.09 EJECTION FRACTION DECREASED | 5 0.05 36.14 ELECTROCARDIOGRAM PR SHORTENED | 1 0.01 36.15 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 36.16 ELECTROCARDIOGRAM QT PROLONGED | 6 0.06 36.22 ELECTROCARDIOGRAM REPOLARISATION ABNO.. | 1 0.01 36.23 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 2 0.02 36.25 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 2 0.02 36.27 ELECTROCARDIOGRAM ST-T CHANGE | 1 0.01 36.28 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL | 1 0.01 36.29 ELECTROCARDIOGRAM T WAVE AMPLITUDE DE.. | 1 0.01 36.30 ELECTROENCEPHALOGRAM ABNORMAL | 3 0.03 36.33 ELECTROLYTE IMBALANCE | 2 0.02 36.35 ELECTROMECHANICAL DISSOCIATION | 2 0.02 36.37 ELEVATED MOOD | 1 0.01 36.38 EMBOLIC STROKE | 2 0.02 36.40 EMBOLISM | 3 0.03 36.43 EMOTIONAL DISORDER | 5 0.05 36.48 EMOTIONAL DISTRESS | 3 0.03 36.51 EMPHYSEMA | 3 0.03 36.54 ENCEPHALITIS | 4 0.04 36.58 ENCEPHALITIS HERPES | 1 0.01 36.59 ENCEPHALITIS JAPANESE B | 1 0.01 36.60 ENCEPHALITIS POST VARICELLA | 1 0.01 36.61 ENCEPHALITIS VIRAL | 2 0.02 36.63 ENCEPHALOPATHY | 6 0.06 36.69 ENDOCARDITIS | 1 0.01 36.70 ENDOMETRIAL ATROPHY | 1 0.01 36.71 ENDOMETRIAL CANCER STAGE IV | 1 0.01 36.72 ENDOMETRIAL DISORDER | 1 0.01 36.73 ENDOMETRIAL HYPERPLASIA | 1 0.01 36.74 ENDOMETRIOSIS | 1 0.01 36.75 ENDOPHTHALMITIS | 2 0.02 36.77 ENDOTOXIC SHOCK | 1 0.01 36.78 ENTERITIS | 2 0.02 36.80 ENTERITIS INFECTIOUS | 1 0.01 36.81 ENTEROCOCCAL INFECTION | 3 0.03 36.84 ENTEROCOCCAL SEPSIS | 2 0.02 36.86 ENTEROCOLITIS | 1 0.01 36.87 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 36.88 ENURESIS | 1 0.01 36.89 ENZYME ABNORMALITY | 2 0.02 36.91 EOSINOPHIL COUNT INCREASED | 3 0.03 36.94 EOSINOPHIL PERCENTAGE INCREASED | 1 0.01 36.95 EOSINOPHILIA | 1 0.01 36.96 EOSINOPHILIC PNEUMONIA | 2 0.02 36.98 EPILEPSY | 6 0.06 37.04 EPIPHYSIOLYSIS | 1 0.01 37.05 EPISCLERITIS | 1 0.01 37.06 EPISTAXIS | 4 0.04 37.10 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE | 1 0.01 37.11 EPSTEIN-BARR VIRUS INFECTION | 3 0.03 37.14 ERECTILE DYSFUNCTION | 2 0.02 37.16 EROSIVE DUODENITIS | 1 0.01 37.17 ERUCTATION | 1 0.01 37.18 ERYSIPELAS | 3 0.03 37.21 ERYTHEMA | 23 0.23 37.44 ERYTHEMA INFECTIOSUM | 1 0.01 37.45 ERYTHEMA MULTIFORME | 2 0.02 37.47 ERYTHEMA NODOSUM | 4 0.04 37.51 ERYTHRODERMIC PSORIASIS | 1 0.01 37.52 ERYTHROPENIA | 2 0.02 37.54 ESCHAR | 1 0.01 37.55 ESCHERICHIA INFECTION | 7 0.07 37.62 ESCHERICHIA SEPSIS | 1 0.01 37.63 EUPHORIC MOOD | 1 0.01 37.64 EXERCISE LACK OF | 1 0.01 37.65 EXERCISE TOLERANCE DECREASED | 1 0.01 37.66 EXOPHTHALMOS | 1 0.01 37.67 EXOSTOSIS | 1 0.01 37.68 EXTENSOR PLANTAR RESPONSE | 1 0.01 37.69 EXTRAPYRAMIDAL DISORDER | 5 0.05 37.74 EXTRAVASATION | 1 0.01 37.75 EXTRAVASATION BLOOD | 1 0.01 37.76 EXTREMITY NECROSIS | 1 0.01 37.77 EYE DISCHARGE | 1 0.01 37.78 EYE DISORDER | 3 0.03 37.81 EYE HAEMORRHAGE | 4 0.04 37.85 EYE INFECTION | 3 0.03 37.88 EYE INFLAMMATION | 4 0.04 37.92 EYE IRRITATION | 4 0.04 37.96 EYE MOVEMENT DISORDER | 2 0.02 37.98 EYE OPERATION | 1 0.01 37.99 EYE PAIN | 5 0.05 38.04 EYE PRURITUS | 2 0.02 38.06 EYE SWELLING | 2 0.02 38.08 EYELID DISORDER | 1 0.01 38.09 EYELID OEDEMA | 4 0.04 38.13 EYELID PTOSIS | 2 0.02 38.15 FACE OEDEMA | 8 0.08 38.23 FACIAL PAIN | 1 0.01 38.24 FACIAL PALSY | 7 0.07 38.31 FACTOR VIII INHIBITION | 3 0.03 38.34 FAECAL INCONTINENCE | 2 0.02 38.36 FAECAL VOMITING | 1 0.01 38.37 FAECALITH | 1 0.01 38.38 FAECES DISCOLOURED | 1 0.01 38.39 FAECES PALE | 1 0.01 38.40 FALL | 49 0.49 38.89 FALLOPIAN TUBE CANCER | 1 0.01 38.90 FAMILY STRESS | 1 0.01 38.91 FANCONI SYNDROME ACQUIRED | 1 0.01 38.92 FAT NECROSIS | 1 0.01 38.93 FATIGUE | 60 0.60 39.53 FEAR | 5 0.05 39.58 FEBRILE NEUTROPENIA | 8 0.08 39.66 FEEDING DISORDER | 1 0.01 39.67 FEELING ABNORMAL | 23 0.23 39.90 FEELING COLD | 1 0.01 39.91 FEELING DRUNK | 1 0.01 39.92 FEELING GUILTY | 1 0.01 39.93 FEELING HOT | 15 0.15 40.08 FEELING HOT AND COLD | 1 0.01 40.09 FEELING JITTERY | 4 0.04 40.13 FEELINGS OF WORTHLESSNESS | 1 0.01 40.14 FEMALE ORGASMIC DISORDER | 1 0.01 40.15 FEMUR FRACTURE | 5 0.05 40.20 FIBRIN D DIMER INCREASED | 2 0.02 40.22 FIBROADENOMA | 1 0.01 40.23 FIBROMYALGIA | 1 0.01 40.24 FIBROSIS | 1 0.01 40.25 FINGER AMPUTATION | 1 0.01 40.26 FINGER HYPOPLASIA | 1 0.01 40.27 FISTULA | 3 0.03 40.30 FLANK PAIN | 2 0.02 40.32 FLATULENCE | 6 0.06 40.38 FLIGHT OF IDEAS | 1 0.01 40.39 FLUID INTAKE REDUCED | 2 0.02 40.41 FLUID OVERLOAD | 4 0.04 40.45 FLUID RETENTION | 5 0.05 40.50 FLUSHING | 10 0.10 40.60 FOAMING AT MOUTH | 1 0.01 40.61 FOCAL GLOMERULOSCLEROSIS | 1 0.01 40.62 FOETAL DISORDER | 1 0.01 40.63 FOETAL DISTRESS SYNDROME | 1 0.01 40.64 FOETAL GROWTH RETARDATION | 2 0.02 40.66 FOETAL HEART RATE DECELERATION | 2 0.02 40.68 FOOD INTOLERANCE | 1 0.01 40.69 FOOD POISONING | 1 0.01 40.70 FOOT DEFORMITY | 1 0.01 40.71 FOOT FRACTURE | 2 0.02 40.73 FOOT OPERATION | 1 0.01 40.74 FORCED EXPIRATORY VOLUME DECREASED | 1 0.01 40.75 FOREIGN BODY ASPIRATION | 1 0.01 40.76 FRACTURE | 1 0.01 40.77 FREQUENT BOWEL MOVEMENTS | 1 0.01 40.78 FUNGAEMIA | 1 0.01 40.79 FUNGAL INFECTION | 3 0.03 40.82 FUNGAL OESOPHAGITIS | 1 0.01 40.83 FUNGAL PERITONITIS | 3 0.03 40.86 FUNGAL SKIN INFECTION | 2 0.02 40.88 FUNGUS BODY FLUID IDENTIFIED | 1 0.01 40.89 FURUNCLE | 1 0.01 40.90 GAIT DISTURBANCE | 41 0.41 41.31 GALACTORRHOEA | 4 0.04 41.35 GALLBLADDER DISORDER | 7 0.07 41.42 GALLBLADDER OPERATION | 1 0.01 41.43 GALLBLADDER PERFORATION | 1 0.01 41.44 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 19 0.19 41.63 GANGRENE | 2 0.02 41.65 GASTRIC ATONY | 1 0.01 41.66 GASTRIC CANCER | 3 0.03 41.69 GASTRIC DISORDER | 2 0.02 41.71 GASTRIC HAEMORRHAGE | 2 0.02 41.73 GASTRIC INFECTION | 1 0.01 41.74 GASTRIC LAVAGE | 1 0.01 41.75 GASTRIC PERFORATION | 3 0.03 41.78 GASTRIC ULCER | 6 0.06 41.84 GASTRIC ULCER PERFORATION | 1 0.01 41.85 GASTRITIS | 11 0.11 41.96 GASTRITIS ATROPHIC | 1 0.01 41.97 GASTRITIS EROSIVE | 1 0.01 41.98 GASTRITIS HAEMORRHAGIC | 2 0.02 42.00 GASTROENTERITIS | 2 0.02 42.02 GASTROENTERITIS NORWALK VIRUS | 1 0.01 42.03 GASTROENTERITIS VIRAL | 1 0.01 42.04 GASTROINTESTINAL CARCINOMA | 1 0.01 42.05 GASTROINTESTINAL DISORDER | 19 0.19 42.24 GASTROINTESTINAL FISTULA | 2 0.02 42.26 GASTROINTESTINAL HAEMORRHAGE | 19 0.19 42.45 GASTROINTESTINAL INFECTION | 1 0.01 42.46 GASTROINTESTINAL MOTILITY DISORDER | 2 0.02 42.48 GASTROINTESTINAL NEOPLASM | 1 0.01 42.49 GASTROINTESTINAL PAIN | 2 0.02 42.51 GASTROINTESTINAL PERFORATION | 1 0.01 42.52 GASTROINTESTINAL ULCER | 1 0.01 42.53 GASTROOESOPHAGEAL REFLUX DISEASE | 7 0.07 42.60 GASTROSTOMY | 1 0.01 42.61 GASTROSTOMY TUBE INSERTION | 1 0.01 42.62 GAZE PALSY | 1 0.01 42.63 GENE MUTATION | 1 0.01 42.64 GENERAL PHYSICAL CONDITION ABNORMAL | 2 0.02 42.66 GENERAL PHYSICAL HEALTH DETERIORATION | 47 0.47 43.13 GENERALISED ANXIETY DISORDER | 2 0.02 43.15 GENERALISED ERYTHEMA | 4 0.04 43.19 GENERALISED OEDEMA | 1 0.01 43.20 GENITAL DISORDER FEMALE | 1 0.01 43.21 GENITALIA EXTERNAL AMBIGUOUS | 1 0.01 43.22 GERM CELL CANCER | 1 0.01 43.23 GINGIVAL BLEEDING | 1 0.01 43.24 GINGIVAL DISCOLOURATION | 1 0.01 43.25 GINGIVAL DISORDER | 1 0.01 43.26 GINGIVAL PAIN | 3 0.03 43.29 GINGIVAL RECESSION | 1 0.01 43.30 GINGIVAL SWELLING | 1 0.01 43.31 GINGIVITIS | 3 0.03 43.34 GLASGOW COMA SCALE ABNORMAL | 1 0.01 43.35 GLOMERULAR FILTRATION RATE DECREASED | 2 0.02 43.37 GLOMERULONEPHRITIS | 1 0.01 43.38 GLOMERULONEPHRITIS PROLIFERATIVE | 2 0.02 43.40 GLOMERULOSCLEROSIS | 1 0.01 43.41 GLOSSITIS | 1 0.01 43.42 GLOSSODYNIA | 2 0.02 43.44 GLUCOSE TOLERANCE IMPAIRED | 2 0.02 43.46 GLUCOSE URINE PRESENT | 1 0.01 43.47 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 43.48 GOITRE | 2 0.02 43.50 GOUT | 3 0.03 43.53 GRAFT DYSFUNCTION | 1 0.01 43.54 GRAFT VERSUS HOST DISEASE | 2 0.02 43.56 GRAND MAL CONVULSION | 9 0.09 43.65 GRANDIOSITY | 1 0.01 43.66 GRANULOCYTES ABNORMAL | 1 0.01 43.67 GRANULOCYTOPENIA | 1 0.01 43.68 GRANULOMATOUS LIVER DISEASE | 2 0.02 43.70 GROIN PAIN | 3 0.03 43.73 GROWTH RETARDATION | 1 0.01 43.74 GUILLAIN-BARRE SYNDROME | 2 0.02 43.76 GUN SHOT WOUND | 1 0.01 43.77 GUTTATE PSORIASIS | 1 0.01 43.78 GYNAECOMASTIA | 1 0.01 43.79 HABITUAL ABORTION | 1 0.01 43.80 HAEMANGIOMA OF LIVER | 1 0.01 43.81 HAEMANGIOMA OF SKIN | 1 0.01 43.82 HAEMARTHROSIS | 1 0.01 43.83 HAEMATEMESIS | 4 0.04 43.87 HAEMATOCHEZIA | 4 0.04 43.91 HAEMATOCRIT DECREASED | 15 0.15 44.06 HAEMATOCRIT INCREASED | 2 0.02 44.08 HAEMATOLOGY TEST ABNORMAL | 2 0.02 44.10 HAEMATOMA | 5 0.05 44.15 HAEMATOMA INFECTION | 1 0.01 44.16 HAEMATURIA | 9 0.09 44.25 HAEMODIALYSIS | 13 0.13 44.38 HAEMODYNAMIC INSTABILITY | 3 0.03 44.41 HAEMOGLOBIN DECREASED | 32 0.32 44.73 HAEMOGLOBIN INCREASED | 3 0.03 44.76 HAEMOLYSIS | 4 0.04 44.80 HAEMOLYTIC ANAEMIA | 5 0.05 44.85 HAEMOLYTIC URAEMIC SYNDROME | 2 0.02 44.87 HAEMOPTYSIS | 8 0.08 44.95 HAEMORRHAGE | 15 0.15 45.10 HAEMORRHAGE INTRACRANIAL | 3 0.03 45.13 HAEMORRHAGE SUBCUTANEOUS | 3 0.03 45.16 HAEMORRHAGIC ASCITES | 1 0.01 45.17 HAEMORRHAGIC DIATHESIS | 3 0.03 45.20 HAEMORRHAGIC STROKE | 1 0.01 45.21 HAEMORRHOID OPERATION | 1 0.01 45.22 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 45.23 HAEMORRHOIDS | 5 0.05 45.28 HAIR GROWTH ABNORMAL | 1 0.01 45.29 HAIR TEXTURE ABNORMAL | 2 0.02 45.31 HALLUCINATION | 24 0.24 45.55 HALLUCINATION, AUDITORY | 1 0.01 45.56 HALLUCINATION, VISUAL | 3 0.03 45.59 HAND FRACTURE | 1 0.01 45.60 HAPTOGLOBIN DECREASED | 1 0.01 45.61 HBV DNA INCREASED | 1 0.01 45.62 HEAD DISCOMFORT | 1 0.01 45.63 HEAD INJURY | 4 0.04 45.67 HEADACHE | 83 0.83 46.50 HEARING IMPAIRED | 4 0.04 46.54 HEART RATE DECREASED | 6 0.06 46.60 HEART RATE INCREASED | 27 0.27 46.87 HEART RATE IRREGULAR | 5 0.05 46.92 HEART VALVE INSUFFICIENCY | 1 0.01 46.93 HEART VALVE REPLACEMENT | 1 0.01 46.94 HEAT EXHAUSTION | 2 0.02 46.96 HELICOBACTER INFECTION | 1 0.01 46.97 HEMIANOPIA HOMONYMOUS | 1 0.01 46.98 HEMIPARESIS | 1 0.01 46.99 HEMIPLEGIA | 1 0.01 47.00 HEMIVERTEBRA | 1 0.01 47.01 HENOCH-SCHONLEIN PURPURA | 3 0.03 47.04 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 47.06 HEPATIC ADENOMA | 1 0.01 47.07 HEPATIC ARTERY THROMBOSIS | 1 0.01 47.08 HEPATIC CIRRHOSIS | 6 0.06 47.14 HEPATIC CONGESTION | 1 0.01 47.15 HEPATIC CYST | 3 0.03 47.18 HEPATIC ENCEPHALOPATHY | 2 0.02 47.20 HEPATIC ENZYME ABNORMAL | 1 0.01 47.21 HEPATIC ENZYME INCREASED | 17 0.17 47.38 HEPATIC FAILURE | 13 0.13 47.51 HEPATIC FIBROSIS | 1 0.01 47.52 HEPATIC FUNCTION ABNORMAL | 19 0.19 47.71 HEPATIC ISCHAEMIA | 1 0.01 47.72 HEPATIC MASS | 1 0.01 47.73 HEPATIC NECROSIS | 2 0.02 47.75 HEPATIC NEOPLASM | 1 0.01 47.76 HEPATIC NEOPLASM MALIGNANT | 1 0.01 47.77 HEPATIC STEATOSIS | 8 0.08 47.85 HEPATIC VEIN THROMBOSIS | 1 0.01 47.86 HEPATITIS | 13 0.13 47.99 HEPATITIS ACUTE | 4 0.04 48.03 HEPATITIS B SURFACE ANTIGEN POSITIVE | 1 0.01 48.04 HEPATITIS C | 3 0.03 48.07 HEPATITIS CHOLESTATIC | 6 0.06 48.13 HEPATITIS FULMINANT | 1 0.01 48.14 HEPATITIS TOXIC | 1 0.01 48.15 HEPATITIS VIRAL | 3 0.03 48.18 HEPATOBILIARY DISEASE | 1 0.01 48.19 HEPATOCELLULAR DAMAGE | 5 0.05 48.24 HEPATOMEGALY | 4 0.04 48.28 HEPATORENAL FAILURE | 1 0.01 48.29 HEPATORENAL SYNDROME | 2 0.02 48.31 HEPATOSPLENOMEGALY | 6 0.06 48.37 HEPATOTOXICITY | 4 0.04 48.41 HERNIA | 2 0.02 48.43 HERPES SIMPLEX | 2 0.02 48.45 HERPES VIRUS INFECTION | 2 0.02 48.47 HERPES ZOSTER | 7 0.07 48.54 HERPES ZOSTER DISSEMINATED | 1 0.01 48.55 HIATUS HERNIA | 1 0.01 48.56 HICCUPS | 1 0.01 48.57 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 48.58 HIGH-PITCHED CRYING | 1 0.01 48.59 HIP ARTHROPLASTY | 2 0.02 48.61 HIP DYSPLASIA | 1 0.01 48.62 HIP FRACTURE | 3 0.03 48.65 HIP SURGERY | 1 0.01 48.66 HISTIOCYTOSIS HAEMATOPHAGIC | 3 0.03 48.69 HISTOLOGY ABNORMAL | 1 0.01 48.70 HISTOPLASMOSIS DISSEMINATED | 1 0.01 48.71 HIV INFECTION | 1 0.01 48.72 HODGKIN'S DISEASE | 2 0.02 48.74 HODGKIN'S DISEASE STAGE IV | 1 0.01 48.75 HORSESHOE KIDNEY | 1 0.01 48.76 HOSPITALISATION | 5 0.05 48.81 HOSTILITY | 2 0.02 48.83 HOT FLUSH | 7 0.07 48.90 HUMERUS FRACTURE | 1 0.01 48.91 HUNGER | 2 0.02 48.93 HUNTINGTON'S CHOREA | 1 0.01 48.94 HYDROCEPHALUS | 4 0.04 48.98 HYDRONEPHROSIS | 6 0.06 49.04 HYDROURETER | 1 0.01 49.05 HYPERAESTHESIA | 1 0.01 49.06 HYPERAMYLASAEMIA | 1 0.01 49.07 HYPERBILIRUBINAEMIA | 1 0.01 49.08 HYPERBILIRUBINAEMIA NEONATAL | 1 0.01 49.09 HYPERCALCAEMIA | 1 0.01 49.10 HYPERCHOLESTEROLAEMIA | 2 0.02 49.12 HYPERCOAGULATION | 1 0.01 49.13 HYPERGAMMAGLOBULINAEMIA | 1 0.01 49.14 HYPERGLYCAEMIA | 12 0.12 49.26 HYPERHIDROSIS | 32 0.32 49.58 HYPERINSULINISM | 1 0.01 49.59 HYPERKALAEMIA | 1 0.01 49.60 HYPERKINESIA | 1 0.01 49.61 HYPERLIPIDAEMIA | 1 0.01 49.62 HYPERPHAGIA | 1 0.01 49.63 HYPERPHOSPHATAEMIA | 1 0.01 49.64 HYPERREFLEXIA | 1 0.01 49.65 HYPERSENSITIVITY | 31 0.31 49.96 HYPERSOMNIA | 4 0.04 50.00 HYPERTENSION | 39 0.39 50.39 HYPERTENSIVE CRISIS | 3 0.03 50.42 HYPERTENSIVE HEART DISEASE | 1 0.01 50.43 HYPERTHERMIA | 4 0.04 50.47 HYPERTHERMIA MALIGNANT | 2 0.02 50.49 HYPERTRIGLYCERIDAEMIA | 3 0.03 50.52 HYPERTROPHIC CARDIOMYOPATHY | 2 0.02 50.54 HYPOACUSIS | 7 0.07 50.61 HYPOAESTHESIA | 18 0.18 50.79 HYPOAESTHESIA ORAL | 3 0.03 50.82 HYPOALBUMINAEMIA | 1 0.01 50.83 HYPOCALCAEMIA | 8 0.08 50.91 HYPOGAMMAGLOBULINAEMIA | 1 0.01 50.92 HYPOGLYCAEMIA | 21 0.21 51.13 HYPOGLYCAEMIA NEONATAL | 1 0.01 51.14 HYPOGLYCAEMIC COMA | 1 0.01 51.15 HYPOKALAEMIA | 16 0.16 51.31 HYPOKINESIA | 1 0.01 51.32 HYPOMAGNESAEMIA | 2 0.02 51.34 HYPOMANIA | 4 0.04 51.38 HYPONATRAEMIA | 17 0.17 51.55 HYPOPHOSPHATAEMIA | 2 0.02 51.57 HYPOSPADIAS | 1 0.01 51.58 HYPOTENSION | 49 0.49 52.07 HYPOTHYROIDISM | 7 0.07 52.14 HYPOTONIA | 2 0.02 52.16 HYPOTONIA NEONATAL | 1 0.01 52.17 HYPOTRICHOSIS | 2 0.02 52.19 HYPOVENTILATION | 1 0.01 52.20 HYPOVOLAEMIA | 1 0.01 52.21 HYPOXIA | 11 0.11 52.32 HYPOXIC ENCEPHALOPATHY | 1 0.01 52.33 HYSTERECTOMY | 3 0.03 52.36 IATROGENIC INJURY | 1 0.01 52.37 ICHTHYOSIS | 2 0.02 52.39 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 52.41 IDIOSYNCRATIC DRUG REACTION | 1 0.01 52.42 IIIRD NERVE PARALYSIS | 2 0.02 52.44 ILEITIS | 1 0.01 52.45 ILEOSTOMY | 1 0.01 52.46 ILEUS | 5 0.05 52.51 ILEUS PARALYTIC | 1 0.01 52.52 ILIAC VEIN OCCLUSION | 1 0.01 52.53 ILL-DEFINED DISORDER | 11 0.11 52.64 ILLUSION | 2 0.02 52.66 IMMOBILE | 1 0.01 52.67 IMMUNE RECONSTITUTION SYNDROME | 3 0.03 52.70 IMMUNE SYSTEM DISORDER | 3 0.03 52.73 IMMUNODEFICIENCY | 4 0.04 52.77 IMMUNOSUPPRESSION | 3 0.03 52.80 IMPAIRED DRIVING ABILITY | 3 0.03 52.83 IMPAIRED GASTRIC EMPTYING | 1 0.01 52.84 IMPAIRED HEALING | 7 0.07 52.91 IMPAIRED WORK ABILITY | 6 0.06 52.97 IMPETIGO | 1 0.01 52.98 IMPLANT SITE EFFUSION | 1 0.01 52.99 IMPLANT SITE FIBROSIS | 1 0.01 53.00 IMPRISONMENT | 1 0.01 53.01 IMPULSIVE BEHAVIOUR | 1 0.01 53.02 INADEQUATE ANALGESIA | 4 0.04 53.06 INADEQUATE LUBRICATION | 1 0.01 53.07 INAPPROPRIATE AFFECT | 1 0.01 53.08 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 53.10 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 9 0.09 53.19 INCISION SITE INFECTION | 1 0.01 53.20 INCOHERENT | 1 0.01 53.21 INCONTINENCE | 6 0.06 53.27 INCORRECT DOSE ADMINISTERED | 18 0.18 53.45 INCORRECT DRUG ADMINISTRATION DURATION | 4 0.04 53.49 INCORRECT DRUG ADMINISTRATION RATE | 1 0.01 53.50 INCORRECT ROUTE OF DRUG ADMINISTRATION | 3 0.03 53.53 INCREASED APPETITE | 3 0.03 53.56 INCREASED BRONCHIAL SECRETION | 2 0.02 53.58 INCREASED TENDENCY TO BRUISE | 2 0.02 53.60 INCREASED UPPER AIRWAY SECRETION | 1 0.01 53.61 INDURATION | 1 0.01 53.62 INFARCTION | 2 0.02 53.64 INFECTION | 13 0.13 53.77 INFECTION PROTOZOAL | 1 0.01 53.78 INFERTILITY | 1 0.01 53.79 INFERTILITY FEMALE | 1 0.01 53.80 INFLAMMATION | 11 0.11 53.91 INFLAMMATORY BOWEL DISEASE | 16 0.16 54.07 INFLUENZA | 3 0.03 54.10 INFLUENZA LIKE ILLNESS | 11 0.11 54.21 INFUSION RELATED REACTION | 14 0.14 54.35 INFUSION SITE DISCOLOURATION | 1 0.01 54.36 INFUSION SITE ERYTHEMA | 1 0.01 54.37 INFUSION SITE EXTRAVASATION | 1 0.01 54.38 INITIAL INSOMNIA | 2 0.02 54.40 INJECTION SITE ABSCESS | 1 0.01 54.41 INJECTION SITE ATROPHY | 1 0.01 54.42 INJECTION SITE BRUISING | 4 0.04 54.46 INJECTION SITE DISCOLOURATION | 1 0.01 54.47 INJECTION SITE ERYTHEMA | 3 0.03 54.50 INJECTION SITE HAEMATOMA | 1 0.01 54.51 INJECTION SITE HAEMORRHAGE | 2 0.02 54.53 INJECTION SITE INFECTION | 2 0.02 54.55 INJECTION SITE IRRITATION | 2 0.02 54.57 INJECTION SITE PAIN | 9 0.09 54.66 INJECTION SITE PRURITUS | 1 0.01 54.67 INJECTION SITE REACTION | 6 0.06 54.73 INJECTION SITE SWELLING | 2 0.02 54.75 INJECTION SITE WARMTH | 1 0.01 54.76 INJURY | 14 0.14 54.90 INSOMNIA | 34 0.34 55.24 INTENTIONAL DRUG MISUSE | 7 0.07 55.31 INTENTIONAL OVERDOSE | 11 0.11 55.42 INTENTIONAL SELF-INJURY | 4 0.04 55.46 INTERCEPTED DRUG ADMINISTRATION ERROR | 1 0.01 55.47 INTERCEPTED DRUG DISPENSING ERROR | 9 0.09 55.56 INTERCEPTED MEDICATION ERROR | 1 0.01 55.57 INTERCOSTAL RETRACTION | 1 0.01 55.58 INTERMITTENT CLAUDICATION | 1 0.01 55.59 INTERMITTENT EXPLOSIVE DISORDER | 2 0.02 55.61 INTERNATIONAL NORMALISED RATIO DECREA.. | 5 0.05 55.66 INTERNATIONAL NORMALISED RATIO INCREA.. | 14 0.14 55.80 INTERSTITIAL LUNG DISEASE | 24 0.24 56.04 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 56.05 INTERVERTEBRAL DISC DISORDER | 1 0.01 56.06 INTERVERTEBRAL DISC PROTRUSION | 5 0.05 56.11 INTERVERTEBRAL DISCITIS | 2 0.02 56.13 INTESTINAL HAEMORRHAGE | 7 0.07 56.20 INTESTINAL OBSTRUCTION | 5 0.05 56.25 INTESTINAL OPERATION | 1 0.01 56.26 INTESTINAL PERFORATION | 3 0.03 56.29 INTESTINAL RESECTION | 1 0.01 56.30 INTRA-UTERINE DEATH | 5 0.05 56.35 INTRACARDIAC THROMBUS | 4 0.04 56.39 INTRACRANIAL PRESSURE INCREASED | 2 0.02 56.41 INTRACRANIAL VENOUS SINUS THROMBOSIS | 2 0.02 56.43 INTRAOCULAR LENS EXTRACTION | 1 0.01 56.44 INTRAOCULAR PRESSURE INCREASED | 4 0.04 56.48 INTRAVENTRICULAR HAEMORRHAGE | 2 0.02 56.50 INTUBATION | 2 0.02 56.52 IRIS ATROPHY | 1 0.01 56.53 IRIS INJURY | 1 0.01 56.54 IRON DEFICIENCY | 1 0.01 56.55 IRON DEFICIENCY ANAEMIA | 2 0.02 56.57 IRREGULAR SLEEP PHASE | 1 0.01 56.58 IRRITABILITY | 9 0.09 56.67 IRRITABLE BOWEL SYNDROME | 7 0.07 56.74 ISCHAEMIA | 2 0.02 56.76 ISCHAEMIC STROKE | 3 0.03 56.79 JAUNDICE | 12 0.12 56.91 JAUNDICE NEONATAL | 1 0.01 56.92 JAW DISORDER | 1 0.01 56.93 JOINT CREPITATION | 1 0.01 56.94 JOINT DISLOCATION | 2 0.02 56.96 JOINT HYPEREXTENSION | 1 0.01 56.97 JOINT INJURY | 2 0.02 56.99 JOINT LOCK | 1 0.01 57.00 JOINT SPRAIN | 2 0.02 57.02 JOINT STIFFNESS | 1 0.01 57.03 JOINT SWELLING | 6 0.06 57.09 JUVENILE ARTHRITIS | 2 0.02 57.11 KAPOSI'S SARCOMA | 3 0.03 57.14 KAWASAKI'S DISEASE | 1 0.01 57.15 KERATITIS | 1 0.01 57.16 KERATITIS HERPETIC | 1 0.01 57.17 KERATOPATHY | 1 0.01 57.18 KETOACIDOSIS | 2 0.02 57.20 KETONURIA | 1 0.01 57.21 KIDNEY FIBROSIS | 1 0.01 57.22 KIDNEY INFECTION | 5 0.05 57.27 KIDNEY SMALL | 1 0.01 57.28 KIDNEY TRANSPLANT REJECTION | 4 0.04 57.32 KLEBSIELLA INFECTION | 2 0.02 57.34 KNEE ARTHROPLASTY | 5 0.05 57.39 KNEE OPERATION | 3 0.03 57.42 KYPHOSIS | 2 0.02 57.44 LABILE BLOOD PRESSURE | 1 0.01 57.45 LABORATORY TEST ABNORMAL | 5 0.05 57.50 LABORATORY TEST INTERFERENCE | 1 0.01 57.51 LABYRINTHITIS | 1 0.01 57.52 LACERATION | 2 0.02 57.54 LACRIMAL DISORDER | 1 0.01 57.55 LACRIMATION INCREASED | 4 0.04 57.59 LACTATION DISORDER | 1 0.01 57.60 LACTIC ACIDOSIS | 6 0.06 57.66 LAPAROTOMY | 1 0.01 57.67 LARGE INTESTINAL ULCER | 1 0.01 57.68 LARYNGEAL DISORDER | 1 0.01 57.69 LARYNGEAL OEDEMA | 6 0.06 57.75 LARYNGITIS | 1 0.01 57.76 LARYNGOSPASM | 2 0.02 57.78 LEG AMPUTATION | 1 0.01 57.79 LEGAL PROBLEM | 3 0.03 57.82 LEGIONELLA INFECTION | 1 0.01 57.83 LEISHMANIASIS | 1 0.01 57.84 LETHARGY | 11 0.11 57.95 LEUKAEMIA | 3 0.03 57.98 LEUKOCYTOCLASTIC VASCULITIS | 3 0.03 58.01 LEUKOCYTOSIS | 1 0.01 58.02 LEUKOCYTURIA | 1 0.01 58.03 LEUKOENCEPHALOPATHY | 2 0.02 58.05 LEUKOPENIA | 14 0.14 58.19 LIBIDO DECREASED | 2 0.02 58.21 LIBIDO DISORDER | 1 0.01 58.22 LICHEN PLANUS | 1 0.01 58.23 LIFE SUPPORT | 1 0.01 58.24 LIMB DEFORMITY | 2 0.02 58.26 LIMB INJURY | 3 0.03 58.29 LIMB OPERATION | 1 0.01 58.30 LIP DRY | 4 0.04 58.34 LIP ULCERATION | 1 0.01 58.35 LIPASE INCREASED | 2 0.02 58.37 LIPIDS INCREASED | 1 0.01 58.38 LIPOATROPHY | 2 0.02 58.40 LISTERIA ENCEPHALITIS | 1 0.01 58.41 LISTERIOSIS | 1 0.01 58.42 LIVEDO RETICULARIS | 1 0.01 58.43 LIVER ABSCESS | 3 0.03 58.46 LIVER DISORDER | 21 0.21 58.67 LIVER FUNCTION TEST ABNORMAL | 10 0.10 58.77 LIVER TRANSPLANT REJECTION | 1 0.01 58.78 LOBAR PNEUMONIA | 2 0.02 58.80 LOCAL SWELLING | 2 0.02 58.82 LOCALISED INFECTION | 6 0.06 58.88 LOGORRHOEA | 1 0.01 58.89 LOOSE TOOTH | 2 0.02 58.91 LOSS OF CONSCIOUSNESS | 48 0.48 59.39 LOSS OF CONTROL OF LEGS | 1 0.01 59.40 LOSS OF EMPLOYMENT | 1 0.01 59.41 LOSS OF LIBIDO | 1 0.01 59.42 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 59.43 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 59.44 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 59.46 LUMBAR SPINAL STENOSIS | 1 0.01 59.47 LUNG ADENOCARCINOMA METASTATIC | 1 0.01 59.48 LUNG CANCER METASTATIC | 1 0.01 59.49 LUNG DISORDER | 10 0.10 59.59 LUNG INFECTION | 3 0.03 59.62 LUNG INFILTRATION | 10 0.10 59.72 LUNG NEOPLASM | 1 0.01 59.73 LUNG NEOPLASM MALIGNANT | 2 0.02 59.75 LUNG TRANSPLANT | 1 0.01 59.76 LUNG TRANSPLANT REJECTION | 1 0.01 59.77 LUPUS NEPHRITIS | 1 0.01 59.78 LUPUS-LIKE SYNDROME | 2 0.02 59.80 LYME DISEASE | 1 0.01 59.81 LYMPHADENITIS | 2 0.02 59.83 LYMPHADENITIS BACTERIAL | 1 0.01 59.84 LYMPHADENOPATHY | 10 0.10 59.94 LYMPHANGITIS | 1 0.01 59.95 LYMPHOCYTE COUNT DECREASED | 1 0.01 59.96 LYMPHOCYTE PERCENTAGE DECREASED | 1 0.01 59.97 LYMPHOCYTOSIS | 1 0.01 59.98 LYMPHOEDEMA | 4 0.04 60.02 LYMPHOMA | 5 0.05 60.07 LYMPHOPENIA | 2 0.02 60.09 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 60.10 MACULAR DEGENERATION | 2 0.02 60.12 MACULAR OEDEMA | 2 0.02 60.14 MACULOPATHY | 1 0.01 60.15 MAJOR DEPRESSION | 5 0.05 60.20 MALAISE | 47 0.47 60.67 MALARIA | 1 0.01 60.68 MALIGNANT BREAST LUMP REMOVAL | 1 0.01 60.69 MALIGNANT MELANOMA | 3 0.03 60.72 MALIGNANT NEOPLASM PROGRESSION | 17 0.17 60.89 MALIGNANT TRANSFORMATION | 1 0.01 60.90 MALNUTRITION | 6 0.06 60.96 MAMMOGRAM ABNORMAL | 1 0.01 60.97 MANIA | 3 0.03 61.00 MARROW HYPERPLASIA | 3 0.03 61.03 MASKED FACIES | 1 0.01 61.04 MASTOID DISORDER | 1 0.01 61.05 MATERNAL CONDITION AFFECTING FOETUS | 1 0.01 61.06 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 61.07 MEAN CELL HAEMOGLOBIN CONCENTRATION | 1 0.01 61.08 MEAN CELL HAEMOGLOBIN DECREASED | 1 0.01 61.09 MEAN CELL VOLUME DECREASED | 1 0.01 61.10 MECONIUM STAIN | 2 0.02 61.12 MEDICAL DEVICE COMPLICATION | 1 0.01 61.13 MEDICAL DEVICE REMOVAL | 1 0.01 61.14 MEDICATION ERROR | 78 0.78 61.92 MEGACOLON | 1 0.01 61.93 MELAENA | 8 0.08 62.01 MEMORY IMPAIRMENT | 10 0.10 62.11 MENIERE'S DISEASE | 1 0.01 62.12 MENINGISM | 2 0.02 62.14 MENINGITIS | 5 0.05 62.19 MENINGITIS ASEPTIC | 1 0.01 62.20 MENINGITIS LISTERIA | 1 0.01 62.21 MENINGITIS VIRAL | 1 0.01 62.22 MENOPAUSE | 1 0.01 62.23 MENORRHAGIA | 2 0.02 62.25 MENSTRUAL DISORDER | 1 0.01 62.26 MENTAL DISORDER | 5 0.05 62.31 MENTAL IMPAIRMENT | 2 0.02 62.33 MENTAL RETARDATION SEVERITY UNSPECIFIED | 2 0.02 62.35 MENTAL STATUS CHANGES | 8 0.08 62.43 METABOLIC ACIDOSIS | 8 0.08 62.51 METABOLIC DISORDER | 5 0.05 62.56 METABOLIC ENCEPHALOPATHY | 3 0.03 62.59 METASTASES TO ABDOMINAL CAVITY | 2 0.02 62.61 METASTASES TO BONE | 2 0.02 62.63 METASTASES TO CENTRAL NERVOUS SYSTEM | 5 0.05 62.68 METASTASES TO CHEST WALL | 1 0.01 62.69 METASTASES TO LIVER | 3 0.03 62.72 METASTASES TO LUNG | 3 0.03 62.75 METASTASES TO LYMPH NODES | 2 0.02 62.77 METASTASES TO OVARY | 1 0.01 62.78 METASTASES TO PANCREAS | 1 0.01 62.79 METASTASES TO SPINE | 1 0.01 62.80 METASTASIS | 1 0.01 62.81 METASTATIC NEOPLASM | 1 0.01 62.82 METASTATIC RENAL CELL CARCINOMA | 3 0.03 62.85 METHAEMOGLOBINAEMIA | 1 0.01 62.86 METRORRHAGIA | 1 0.01 62.87 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA | 1 0.01 62.88 MICROCYTIC ANAEMIA | 5 0.05 62.93 MICTURITION FREQUENCY DECREASED | 1 0.01 62.94 MICTURITION URGENCY | 6 0.06 63.00 MIDDLE INSOMNIA | 2 0.02 63.02 MIGRAINE | 5 0.05 63.07 MILK ALLERGY | 1 0.01 63.08 MILLER FISHER SYNDROME | 1 0.01 63.09 MIOSIS | 1 0.01 63.10 MITRAL VALVE INCOMPETENCE | 4 0.04 63.14 MITRAL VALVE PROLAPSE | 1 0.01 63.15 MITRAL VALVE STENOSIS | 1 0.01 63.16 MOBILITY DECREASED | 3 0.03 63.19 MONOCYTE COUNT INCREASED | 1 0.01 63.20 MONOCYTE PERCENTAGE INCREASED | 1 0.01 63.21 MONOPARESIS | 1 0.01 63.22 MONOPLEGIA | 3 0.03 63.25 MOOD ALTERED | 1 0.01 63.26 MOOD SWINGS | 1 0.01 63.27 MORBID THOUGHTS | 1 0.01 63.28 MOTION SICKNESS | 1 0.01 63.29 MOTOR DYSFUNCTION | 3 0.03 63.32 MOUTH HAEMORRHAGE | 2 0.02 63.34 MOUTH ULCERATION | 7 0.07 63.41 MOVEMENT DISORDER | 9 0.09 63.50 MUCORMYCOSIS | 1 0.01 63.51 MUCOSAL EROSION | 1 0.01 63.52 MUCOSAL INFLAMMATION | 8 0.08 63.60 MULTI-ORGAN DISORDER | 5 0.05 63.65 MULTI-ORGAN FAILURE | 10 0.10 63.75 MULTIPLE CONGENITAL ABNORMALITIES | 1 0.01 63.76 MULTIPLE DRUG OVERDOSE | 3 0.03 63.79 MULTIPLE DRUG OVERDOSE INTENTIONAL | 5 0.05 63.84 MULTIPLE MYELOMA | 2 0.02 63.86 MULTIPLE SCLEROSIS | 4 0.04 63.90 MULTIPLE-DRUG RESISTANCE | 2 0.02 63.92 MUSCLE ATROPHY | 2 0.02 63.94 MUSCLE DISORDER | 3 0.03 63.97 MUSCLE INJURY | 1 0.01 63.98 MUSCLE NECROSIS | 1 0.01 63.99 MUSCLE RIGIDITY | 11 0.11 64.10 MUSCLE SPASMS | 27 0.27 64.37 MUSCLE SPASTICITY | 2 0.02 64.39 MUSCLE TIGHTNESS | 2 0.02 64.41 MUSCLE TWITCHING | 3 0.03 64.44 MUSCULAR WEAKNESS | 25 0.25 64.69 MUSCULOSKELETAL CHEST PAIN | 4 0.04 64.73 MUSCULOSKELETAL PAIN | 8 0.08 64.81 MUSCULOSKELETAL STIFFNESS | 10 0.10 64.91 MUTISM | 1 0.01 64.92 MYALGIA | 41 0.41 65.33 MYASTHENIA GRAVIS | 2 0.02 65.35 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 65.36 MYELITIS TRANSVERSE | 2 0.02 65.38 MYELODYSPLASTIC SYNDROME | 4 0.04 65.42 MYELOFIBROSIS | 1 0.01 65.43 MYOCARDIAL INFARCTION | 28 0.28 65.71 MYOCARDIAL ISCHAEMIA | 3 0.03 65.74 MYOCARDITIS | 3 0.03 65.77 MYOCLONUS | 5 0.05 65.82 MYOGLOBIN URINE PRESENT | 1 0.01 65.83 MYOGLOBINURIA | 2 0.02 65.85 MYOPATHY | 1 0.01 65.86 MYOSITIS | 1 0.01 65.87 NAIL DISCOLOURATION | 1 0.01 65.88 NAIL DISORDER | 4 0.04 65.92 NARCOLEPSY | 1 0.01 65.93 NASAL CONGESTION | 2 0.02 65.95 NASAL DISCOMFORT | 3 0.03 65.98 NASAL DISORDER | 1 0.01 65.99 NASAL DRYNESS | 1 0.01 66.00 NASAL FLARING | 1 0.01 66.01 NASAL POLYPS | 1 0.01 66.02 NASAL SEPTUM DEVIATION | 1 0.01 66.03 NASOPHARYNGEAL DISORDER | 2 0.02 66.05 NASOPHARYNGITIS | 3 0.03 66.08 NAUSEA | 100 1.00 67.08 NECK INJURY | 1 0.01 67.09 NECK PAIN | 6 0.06 67.15 NECROSIS | 4 0.04 67.19 NECROTISING ENTEROCOLITIS NEONATAL | 4 0.04 67.23 NECROTISING FASCIITIS | 4 0.04 67.27 NECROTISING RETINITIS | 2 0.02 67.29 NEGATIVE THOUGHTS | 2 0.02 67.31 NEONATAL ASPIRATION | 1 0.01 67.32 NEONATAL DISORDER | 1 0.01 67.33 NEONATAL RESPIRATORY DEPRESSION | 1 0.01 67.34 NEONATAL RESPIRATORY DISTRESS SYNDROME | 1 0.01 67.35 NEOPLASM | 2 0.02 67.37 NEOPLASM MALIGNANT | 7 0.07 67.44 NEOPLASM PROGRESSION | 3 0.03 67.47 NEPHRITIS INTERSTITIAL | 4 0.04 67.51 NEPHROLITHIASIS | 9 0.09 67.60 NEPHROPATHY | 1 0.01 67.61 NEPHROPATHY TOXIC | 1 0.01 67.62 NEPHROTIC SYNDROME | 3 0.03 67.65 NERVE COMPRESSION | 1 0.01 67.66 NERVOUS SYSTEM DISORDER | 17 0.17 67.83 NERVOUSNESS | 10 0.10 67.93 NEURALGIA | 4 0.04 67.97 NEURILEMMOMA BENIGN | 1 0.01 67.98 NEURODERMATITIS | 1 0.01 67.99 NEUROGENIC BLADDER | 1 0.01 68.00 NEUROLEPTIC MALIGNANT SYNDROME | 9 0.09 68.09 NEUROLOGICAL SYMPTOM | 1 0.01 68.10 NEUROPATHY | 7 0.07 68.17 NEUROPATHY PERIPHERAL | 4 0.04 68.21 NEUROTOXICITY | 2 0.02 68.23 NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 68.24 NEUTROPENIA | 30 0.30 68.54 NEUTROPHIL COUNT | 1 0.01 68.55 NEUTROPHIL COUNT DECREASED | 4 0.04 68.59 NEUTROPHIL COUNT INCREASED | 3 0.03 68.62 NEUTROPHIL PERCENTAGE DECREASED | 1 0.01 68.63 NEUTROPHIL PERCENTAGE INCREASED | 3 0.03 68.66 NIGHT BLINDNESS | 2 0.02 68.68 NIGHT SWEATS | 6 0.06 68.74 NIGHTMARE | 8 0.08 68.82 NO ADVERSE DRUG EFFECT | 2 0.02 68.84 NO ADVERSE EFFECT | 6 0.06 68.90 NO THERAPEUTIC RESPONSE | 1 0.01 68.91 NOCARDIOSIS | 1 0.01 68.92 NOCTURIA | 1 0.01 68.93 NODAL RHYTHM | 1 0.01 68.94 NODULE | 4 0.04 68.98 NODULE ON EXTREMITY | 2 0.02 69.00 NON-CARDIAC CHEST PAIN | 2 0.02 69.02 NON-HODGKIN'S LYMPHOMA | 2 0.02 69.04 NONSPECIFIC REACTION | 3 0.03 69.07 NORMAL DELIVERY | 1 0.01 69.08 NORMAL NEWBORN | 1 0.01 69.09 NORMOCHROMIC NORMOCYTIC ANAEMIA | 4 0.04 69.13 NUCHAL RIGIDITY | 1 0.01 69.14 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 69.15 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 2 0.02 69.17 NUTRITIONAL CONDITION ABNORMAL | 2 0.02 69.19 NYSTAGMUS | 1 0.01 69.20 OBESITY | 8 0.08 69.28 OBLITERATIVE BRONCHIOLITIS | 3 0.03 69.31 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 69.34 OBSTRUCTION | 2 0.02 69.36 OBSTRUCTIVE AIRWAYS DISORDER | 2 0.02 69.38 OCULAR HYPERAEMIA | 7 0.07 69.45 ODYNOPHAGIA | 4 0.04 69.49 OEDEMA | 8 0.08 69.57 OEDEMA MOUTH | 1 0.01 69.58 OEDEMA PERIPHERAL | 49 0.49 70.07 OESOPHAGEAL CANDIDIASIS | 1 0.01 70.08 OESOPHAGEAL CARCINOMA | 2 0.02 70.10 OESOPHAGEAL DISORDER | 1 0.01 70.11 OESOPHAGEAL HAEMORRHAGE | 1 0.01 70.12 OESOPHAGEAL OEDEMA | 1 0.01 70.13 OESOPHAGEAL OPERATION | 1 0.01 70.14 OESOPHAGEAL PAIN | 1 0.01 70.15 OESOPHAGEAL STENOSIS | 1 0.01 70.16 OESOPHAGEAL ULCER | 1 0.01 70.17 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 70.18 OESOPHAGITIS | 9 0.09 70.27 OESOPHAGITIS ULCERATIVE | 2 0.02 70.29 OESTROGEN RECEPTOR ASSAY POSITIVE | 2 0.02 70.31 OFF LABEL USE | 1 0.01 70.32 OLIGURIA | 2 0.02 70.34 ONYCHOCLASIS | 1 0.01 70.35 ONYCHOMADESIS | 1 0.01 70.36 ONYCHOMYCOSIS | 1 0.01 70.37 OPEN WOUND | 4 0.04 70.41 OPPORTUNISTIC INFECTION | 1 0.01 70.42 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 70.43 OPTIC NEURITIS | 1 0.01 70.44 OPTIC NEURITIS RETROBULBAR | 1 0.01 70.45 ORAL CANDIDIASIS | 4 0.04 70.49 ORAL DISCOMFORT | 2 0.02 70.51 ORAL INFECTION | 1 0.01 70.52 ORAL INTAKE REDUCED | 9 0.09 70.61 ORAL MUCOSA ATROPHY | 1 0.01 70.62 ORAL MUCOSAL BLISTERING | 3 0.03 70.65 ORAL MUCOSAL EXFOLIATION | 1 0.01 70.66 ORAL PAIN | 4 0.04 70.70 ORAL SOFT TISSUE DISORDER | 6 0.06 70.76 ORAL SURGERY | 1 0.01 70.77 ORBITAL INFECTION | 1 0.01 70.78 ORGASM ABNORMAL | 1 0.01 70.79 ORTHOPNOEA | 1 0.01 70.80 ORTHOSTATIC HYPOTENSION | 5 0.05 70.85 ORTHOSTATIC INTOLERANCE | 1 0.01 70.86 OSCILLOPSIA | 1 0.01 70.87 OSTEITIS | 1 0.01 70.88 OSTEOARTHRITIS | 3 0.03 70.91 OSTEOLYSIS | 3 0.03 70.94 OSTEOMYELITIS | 6 0.06 71.00 OSTEONECROSIS | 38 0.38 71.38 OSTEOPENIA | 1 0.01 71.39 OSTEOPOROSIS | 6 0.06 71.45 OSTEOPOROTIC FRACTURE | 1 0.01 71.46 OSTEOSCLEROSIS | 1 0.01 71.47 OSTEOSYNTHESIS | 1 0.01 71.48 OTITIS EXTERNA | 2 0.02 71.50 OTITIS MEDIA | 2 0.02 71.52 OTITIS MEDIA BACTERIAL | 1 0.01 71.53 OVARIAN CANCER | 2 0.02 71.55 OVARIAN CYST | 1 0.01 71.56 OVERDOSE | 31 0.31 71.87 OVERWEIGHT | 2 0.02 71.89 OXYGEN SATURATION DECREASED | 11 0.11 72.00 OXYGEN SUPPLEMENTATION | 1 0.01 72.01 PAIN | 57 0.57 72.58 PAIN IN EXTREMITY | 55 0.55 73.13 PAIN IN JAW | 10 0.10 73.23 PAIN OF SKIN | 1 0.01 73.24 PAINFUL DEFAECATION | 1 0.01 73.25 PALATAL OEDEMA | 1 0.01 73.26 PALLANAESTHESIA | 1 0.01 73.27 PALLOR | 8 0.08 73.35 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 4 0.04 73.39 PALPITATIONS | 19 0.19 73.58 PANCREAS LIPOMATOSIS | 1 0.01 73.59 PANCREAS TRANSPLANT REJECTION | 1 0.01 73.60 PANCREATECTOMY | 1 0.01 73.61 PANCREATIC ATROPHY | 1 0.01 73.62 PANCREATIC CARCINOMA | 1 0.01 73.63 PANCREATIC ENLARGEMENT | 1 0.01 73.64 PANCREATIC PHLEGMON | 1 0.01 73.65 PANCREATITIS | 13 0.13 73.78 PANCREATITIS ACUTE | 7 0.07 73.85 PANCREATITIS NECROTISING | 2 0.02 73.87 PANCYTOPENIA | 21 0.21 74.08 PANIC ATTACK | 8 0.08 74.16 PANIC DISORDER | 1 0.01 74.17 PANNICULITIS | 1 0.01 74.18 PAPILLITIS | 1 0.01 74.19 PAPILLOEDEMA | 1 0.01 74.20 PAPILLOMA VIRAL INFECTION | 1 0.01 74.21 PARAESTHESIA | 19 0.19 74.40 PARAESTHESIA ORAL | 3 0.03 74.43 PARALYSIS | 4 0.04 74.47 PARANEOPLASTIC SYNDROME | 1 0.01 74.48 PARANOIA | 3 0.03 74.51 PARAPLEGIA | 3 0.03 74.54 PARAPROTEINAEMIA | 1 0.01 74.55 PARAPSORIASIS | 1 0.01 74.56 PARKINSON'S DISEASE | 1 0.01 74.57 PARKINSONISM | 2 0.02 74.59 PAROPHTHALMIA | 1 0.01 74.60 PAROSMIA | 1 0.01 74.61 PAROTID GLAND ENLARGEMENT | 1 0.01 74.62 PAROVARIAN CYST | 1 0.01 74.63 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 2 0.02 74.65 PARTIAL SEIZURES | 1 0.01 74.66 PARVOVIRUS B19 SEROLOGY POSITIVE | 1 0.01 74.67 PARVOVIRUS INFECTION | 1 0.01 74.68 PATELLOFEMORAL PAIN SYNDROME | 1 0.01 74.69 PATHOGEN RESISTANCE | 1 0.01 74.70 PATHOLOGICAL FRACTURE | 2 0.02 74.72 PELVIC INFECTION | 1 0.01 74.73 PELVIC VENOUS THROMBOSIS | 1 0.01 74.74 PEMPHIGOID | 1 0.01 74.75 PENILE PAIN | 1 0.01 74.76 PENILE VASCULAR DISORDER | 1 0.01 74.77 PEPTIC ULCER HAEMORRHAGE | 1 0.01 74.78 PERFORATED ULCER | 1 0.01 74.79 PERFORMANCE STATUS DECREASED | 1 0.01 74.80 PERIANAL ABSCESS | 1 0.01 74.81 PERICARDIAL EFFUSION | 9 0.09 74.90 PERICARDITIS | 3 0.03 74.93 PERINEAL ABSCESS | 1 0.01 74.94 PERIODONTITIS | 1 0.01 74.95 PERIORBITAL CELLULITIS | 1 0.01 74.96 PERIORBITAL HAEMATOMA | 1 0.01 74.97 PERIORBITAL OEDEMA | 3 0.03 75.00 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 75.01 PERIPHERAL COLDNESS | 1 0.01 75.02 PERIPHERAL ISCHAEMIA | 1 0.01 75.03 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 75.04 PERIPHERAL SENSORY NEUROPATHY | 3 0.03 75.07 PERIRECTAL ABSCESS | 1 0.01 75.08 PERIRENAL HAEMATOMA | 1 0.01 75.09 PERITONEAL HAEMORRHAGE | 3 0.03 75.12 PERITONEAL TUBERCULOSIS | 1 0.01 75.13 PERITONITIS | 5 0.05 75.18 PERITONITIS BACTERIAL | 3 0.03 75.21 PERONEAL NERVE PALSY | 1 0.01 75.22 PERSONALITY CHANGE | 1 0.01 75.23 PERSONALITY DISORDER | 1 0.01 75.24 PETECHIAE | 2 0.02 75.26 PETIT MAL EPILEPSY | 1 0.01 75.27 PEYRONIE'S DISEASE | 1 0.01 75.28 PHAEOCHROMOCYTOMA | 1 0.01 75.29 PHARMACEUTICAL PRODUCT COMPLAINT | 45 0.45 75.74 PHARMACEUTICAL PRODUCT COUNTERFEIT | 1 0.01 75.75 PHARYNGEAL OEDEMA | 7 0.07 75.82 PHARYNGITIS | 5 0.05 75.87 PHARYNGITIS STREPTOCOCCAL | 1 0.01 75.88 PHARYNGOLARYNGEAL PAIN | 11 0.11 75.99 PHLEBITIS | 1 0.01 76.00 PHOTOPHOBIA | 3 0.03 76.03 PHOTOPSIA | 4 0.04 76.07 PHOTOSENSITIVITY REACTION | 2 0.02 76.09 PHYSICAL ASSAULT | 4 0.04 76.13 PHYSICAL DISABILITY | 1 0.01 76.14 PIGMENTATION DISORDER | 1 0.01 76.15 PILONIDAL CYST | 1 0.01 76.16 PITTING OEDEMA | 1 0.01 76.17 PITUITARY TUMOUR | 1 0.01 76.18 PITUITARY TUMOUR BENIGN | 2 0.02 76.20 PITUITARY TUMOUR RECURRENT | 1 0.01 76.21 PLACENTA PRAEVIA | 1 0.01 76.22 PLACENTAL DISORDER | 1 0.01 76.23 PLACENTAL INFARCTION | 1 0.01 76.24 PLACENTAL INSUFFICIENCY | 2 0.02 76.26 PLASMACYTOSIS | 1 0.01 76.27 PLASMAPHERESIS | 1 0.01 76.28 PLASTIC SURGERY | 1 0.01 76.29 PLATELET AGGREGATION DECREASED | 1 0.01 76.30 PLATELET COUNT DECREASED | 27 0.27 76.57 PLATELET COUNT INCREASED | 3 0.03 76.60 PLATELET FUNCTION TEST ABNORMAL | 1 0.01 76.61 PLEURAL EFFUSION | 24 0.24 76.85 PLEURAL FIBROSIS | 2 0.02 76.87 PLEURISY | 1 0.01 76.88 PLEURITIC PAIN | 1 0.01 76.89 PLEUROTHOTONUS | 1 0.01 76.90 PNEUMOCOCCAL INFECTION | 1 0.01 76.91 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 76.92 PNEUMOCYSTIS JIROVECI PNEUMONIA | 11 0.11 77.03 PNEUMONIA | 50 0.50 77.53 PNEUMONIA ASPIRATION | 10 0.10 77.63 PNEUMONIA BACTERIAL | 1 0.01 77.64 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 77.65 PNEUMONIA KLEBSIELLA | 1 0.01 77.66 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 77.67 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 77.68 PNEUMONIA VIRAL | 2 0.02 77.70 PNEUMONITIS | 8 0.08 77.78 PNEUMOPERITONEUM | 1 0.01 77.79 PNEUMOTHORAX | 4 0.04 77.83 PNEUMOTHORAX TRAUMATIC | 1 0.01 77.84 PO2 DECREASED | 3 0.03 77.87 POISONING DELIBERATE | 6 0.06 77.93 POLLAKIURIA | 6 0.06 77.99 POLYARTERITIS NODOSA | 1 0.01 78.00 POLYARTHRITIS | 3 0.03 78.03 POLYCYSTIC LIVER DISEASE | 1 0.01 78.04 POLYCYTHAEMIA | 1 0.01 78.05 POLYDIPSIA | 3 0.03 78.08 POLYMYALGIA RHEUMATICA | 1 0.01 78.09 POLYMYOSITIS | 1 0.01 78.10 POLYNEUROPATHY | 2 0.02 78.12 POLYP | 1 0.01 78.13 POLYP COLORECTAL | 1 0.01 78.14 POLYPOIDAL CHOROIDAL VASCULOPATHY | 1 0.01 78.15 POLYTRAUMATISM | 17 0.17 78.32 POLYURIA | 2 0.02 78.34 POOR PERIPHERAL CIRCULATION | 1 0.01 78.35 POOR QUALITY DRUG ADMINISTERED | 1 0.01 78.36 POOR QUALITY SLEEP | 3 0.03 78.39 PORTAL HYPERTENSION | 1 0.01 78.40 PORTAL VEIN THROMBOSIS | 4 0.04 78.44 POST PROCEDURAL COMPLICATION | 6 0.06 78.50 POST PROCEDURAL HAEMORRHAGE | 2 0.02 78.52 POST VIRAL FATIGUE SYNDROME | 1 0.01 78.53 POST-TRAUMATIC STRESS DISORDER | 1 0.01 78.54 POSTMATURE BABY | 1 0.01 78.55 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 78.56 POSTNASAL DRIP | 1 0.01 78.57 POSTOPERATIVE INFECTION | 2 0.02 78.59 POSTOPERATIVE WOUND COMPLICATION | 1 0.01 78.60 POSTOPERATIVE WOUND INFECTION | 1 0.01 78.61 POSTURE ABNORMAL | 1 0.01 78.62 PRE-ECLAMPSIA | 2 0.02 78.64 PREGNANCY | 22 0.22 78.86 PREGNANCY TEST URINE POSITIVE | 1 0.01 78.87 PREGNANCY WITH CONTRACEPTIVE DEVICE | 1 0.01 78.88 PREMATURE BABY | 7 0.07 78.95 PREMATURE LABOUR | 4 0.04 78.99 PREMATURE MENOPAUSE | 1 0.01 79.00 PREMATURE RUPTURE OF MEMBRANES | 2 0.02 79.02 PREMATURE SEPARATION OF PLACENTA | 1 0.01 79.03 PREMENSTRUAL SYNDROME | 1 0.01 79.04 PRESCRIBED OVERDOSE | 9 0.09 79.13 PRIAPISM | 2 0.02 79.15 PRIMARY SEQUESTRUM | 1 0.01 79.16 PROCEDURAL COMPLICATION | 4 0.04 79.20 PROCEDURAL PAIN | 1 0.01 79.21 PROCTALGIA | 1 0.01 79.22 PROCTITIS | 1 0.01 79.23 PROCTITIS ULCERATIVE | 3 0.03 79.26 PRODUCTIVE COUGH | 2 0.02 79.28 PROGESTERONE RECEPTOR ASSAY POSITIVE | 1 0.01 79.29 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 1 0.01 79.30 PROSTATE EXAMINATION ABNORMAL | 1 0.01 79.31 PROSTATIC ADENOMA | 1 0.01 79.32 PROSTATIC SPECIFIC ANTIGEN INCREASED | 2 0.02 79.34 PROSTATITIS | 1 0.01 79.35 PROSTHESIS IMPLANTATION | 1 0.01 79.36 PROTEIN S DECREASED | 2 0.02 79.38 PROTEIN TOTAL DECREASED | 5 0.05 79.43 PROTEIN URINE PRESENT | 2 0.02 79.45 PROTEINURIA | 6 0.06 79.51 PROTHROMBIN LEVEL DECREASED | 1 0.01 79.52 PROTHROMBIN TIME ABNORMAL | 1 0.01 79.53 PROTHROMBIN TIME PROLONGED | 6 0.06 79.59 PRURITUS | 33 0.33 79.92 PRURITUS ANI | 1 0.01 79.93 PRURITUS GENERALISED | 4 0.04 79.97 PSEUDOCROUP | 1 0.01 79.98 PSEUDOMEMBRANOUS COLITIS | 1 0.01 79.99 PSEUDOMONAS INFECTION | 5 0.05 80.04 PSORIASIS | 9 0.09 80.13 PSYCHOMOTOR HYPERACTIVITY | 3 0.03 80.16 PSYCHOMOTOR RETARDATION | 1 0.01 80.17 PSYCHOSOMATIC DISEASE | 1 0.01 80.18 PSYCHOTIC DISORDER | 9 0.09 80.27 PULMONARY ALVEOLAR HAEMORRHAGE | 1 0.01 80.28 PULMONARY ARTERY ANEURYSM | 1 0.01 80.29 PULMONARY CONGESTION | 2 0.02 80.31 PULMONARY EMBOLISM | 30 0.30 80.61 PULMONARY FIBROSIS | 1 0.01 80.62 PULMONARY FUNCTION TEST DECREASED | 2 0.02 80.64 PULMONARY HAEMORRHAGE | 4 0.04 80.68 PULMONARY HYPERTENSION | 5 0.05 80.73 PULMONARY INFARCTION | 1 0.01 80.74 PULMONARY MASS | 1 0.01 80.75 PULMONARY OEDEMA | 13 0.13 80.88 PULMONARY THROMBOSIS | 3 0.03 80.91 PULMONARY TOXICITY | 1 0.01 80.92 PULMONARY TUBERCULOSIS | 3 0.03 80.95 PULMONARY VALVE STENOSIS | 3 0.03 80.98 PULMONARY VASCULITIS | 1 0.01 80.99 PULSE ABSENT | 1 0.01 81.00 PUPILLARY LIGHT REFLEX TESTS ABNORMAL | 1 0.01 81.01 PUPILS UNEQUAL | 1 0.01 81.02 PURPURA | 4 0.04 81.06 PURULENCE | 1 0.01 81.07 PURULENT DISCHARGE | 2 0.02 81.09 PUSTULAR PSORIASIS | 2 0.02 81.11 PYELECTASIA | 1 0.01 81.12 PYELONEPHRITIS ACUTE | 1 0.01 81.13 PYELONEPHRITIS CHRONIC | 1 0.01 81.14 PYREXIA | 109 1.09 82.23 QUADRIPARESIS | 1 0.01 82.24 RADIATION PNEUMONITIS | 1 0.01 82.25 RADICULOPATHY | 1 0.01 82.26 RADIOTHERAPY | 1 0.01 82.27 RALES | 3 0.03 82.30 RASH | 50 0.50 82.80 RASH ERYTHEMATOUS | 6 0.06 82.86 RASH GENERALISED | 7 0.07 82.93 RASH MACULAR | 5 0.05 82.98 RASH MACULO-PAPULAR | 3 0.03 83.01 RASH MORBILLIFORM | 2 0.02 83.03 RASH PAPULAR | 3 0.03 83.06 RASH PRURITIC | 2 0.02 83.08 RASH PUSTULAR | 2 0.02 83.10 RASH VESICULAR | 2 0.02 83.12 REACTION TO DRUG EXCIPIENTS | 1 0.01 83.13 REACTIVE ATTACHMENT DISORDER OF INFAN.. | 1 0.01 83.14 REACTIVE PSYCHOSIS | 1 0.01 83.15 READING DISORDER | 1 0.01 83.16 RECTAL HAEMORRHAGE | 10 0.10 83.26 RECTAL PERFORATION | 2 0.02 83.28 RECTOCELE | 2 0.02 83.30 RECTOCELE REPAIR | 1 0.01 83.31 RECURRENT CANCER | 1 0.01 83.32 RED BLOOD CELL ABNORMALITY | 2 0.02 83.34 RED BLOOD CELL COUNT DECREASED | 7 0.07 83.41 RED BLOOD CELL MORPHOLOGY ABNORMAL | 2 0.02 83.43 RED BLOOD CELL SCHISTOCYTES PRESENT | 1 0.01 83.44 RED BLOOD CELLS CSF POSITIVE | 1 0.01 83.45 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 83.46 RED MAN SYNDROME | 1 0.01 83.47 REFLUX OESOPHAGITIS | 1 0.01 83.48 REGRESSIVE BEHAVIOUR | 1 0.01 83.49 REGURGITATION OF FOOD | 1 0.01 83.50 RELAPSING FEVER | 1 0.01 83.51 RENAL ABSCESS | 1 0.01 83.52 RENAL CANCER METASTATIC | 1 0.01 83.53 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 3 0.03 83.56 RENAL COLIC | 1 0.01 83.57 RENAL CYST | 2 0.02 83.59 RENAL DISORDER | 9 0.09 83.68 RENAL FAILURE | 41 0.41 84.09 RENAL FAILURE ACUTE | 39 0.39 84.48 RENAL FAILURE CHRONIC | 2 0.02 84.50 RENAL FUNCTION TEST ABNORMAL | 1 0.01 84.51 RENAL IMPAIRMENT | 29 0.29 84.80 RENAL INFARCT | 1 0.01 84.81 RENAL PAIN | 1 0.01 84.82 RENAL TUBULAR ACIDOSIS | 1 0.01 84.83 RENAL TUBULAR DISORDER | 1 0.01 84.84 RENAL TUBULAR NECROSIS | 4 0.04 84.88 RENAL VEIN THROMBOSIS | 1 0.01 84.89 REPETITIVE STRAIN INJURY | 1 0.01 84.90 RESIDUAL URINE VOLUME | 1 0.01 84.91 RESORPTION BONE INCREASED | 1 0.01 84.92 RESPIRATORY ARREST | 9 0.09 85.01 RESPIRATORY DEPRESSION | 3 0.03 85.04 RESPIRATORY DISORDER | 4 0.04 85.08 RESPIRATORY DISTRESS | 8 0.08 85.16 RESPIRATORY FAILURE | 35 0.35 85.51 RESPIRATORY FUME INHALATION DISORDER | 1 0.01 85.52 RESPIRATORY GAS EXCHANGE DISORDER | 1 0.01 85.53 RESPIRATORY RATE DECREASED | 1 0.01 85.54 RESPIRATORY RATE INCREASED | 2 0.02 85.56 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 85.57 RESPIRATORY TRACT INFECTION | 1 0.01 85.58 RESPIRATORY TRACT IRRITATION | 1 0.01 85.59 RESTLESS LEGS SYNDROME | 3 0.03 85.62 RESTLESSNESS | 9 0.09 85.71 RETCHING | 2 0.02 85.73 RETINAL ARTERY EMBOLISM | 1 0.01 85.74 RETINAL ARTERY OCCLUSION | 2 0.02 85.76 RETINAL ARTERY THROMBOSIS | 1 0.01 85.77 RETINAL DEGENERATION | 1 0.01 85.78 RETINAL DEPOSITS | 2 0.02 85.80 RETINAL DETACHMENT | 6 0.06 85.86 RETINAL DISORDER | 6 0.06 85.92 RETINAL HAEMORRHAGE | 6 0.06 85.98 RETINAL ISCHAEMIA | 1 0.01 85.99 RETINAL OEDEMA | 1 0.01 86.00 RETINAL TEAR | 2 0.02 86.02 RETINAL VEIN OCCLUSION | 3 0.03 86.05 RETINITIS VIRAL | 2 0.02 86.07 RETINOPATHY | 1 0.01 86.08 RETINOPATHY HYPERTENSIVE | 1 0.01 86.09 RETROGRADE AMNESIA | 1 0.01 86.10 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 1 0.01 86.11 RHABDOMYOLYSIS | 20 0.20 86.31 RHEUMATIC HEART DISEASE | 1 0.01 86.32 RHEUMATOID ARTHRITIS | 5 0.05 86.37 RHEUMATOID FACTOR INCREASED | 1 0.01 86.38 RHINORRHOEA | 2 0.02 86.40 RHONCHI | 1 0.01 86.41 ROAD TRAFFIC ACCIDENT | 9 0.09 86.50 SALIVARY GLAND PAIN | 1 0.01 86.51 SALIVARY HYPERSECRETION | 3 0.03 86.54 SALMONELLOSIS | 1 0.01 86.55 SCAR | 3 0.03 86.58 SCAR PAIN | 1 0.01 86.59 SCHIZOPHRENIA | 3 0.03 86.62 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 86.63 SCINTIGRAPHY | 1 0.01 86.64 SCLERAL OEDEMA | 1 0.01 86.65 SCLERODERMA RENAL CRISIS | 1 0.01 86.66 SCLEROSING ENCAPSULATING PERITONITIS | 2 0.02 86.68 SCRATCH | 1 0.01 86.69 SCREAMING | 1 0.01 86.70 SEASONAL ALLERGY | 1 0.01 86.71 SEDATION | 5 0.05 86.76 SELF ESTEEM DECREASED | 1 0.01 86.77 SELF INJURIOUS BEHAVIOUR | 3 0.03 86.80 SELF-INJURIOUS IDEATION | 2 0.02 86.82 SELF-MEDICATION | 3 0.03 86.85 SENSATION OF BLOOD FLOW | 1 0.01 86.86 SENSATION OF HEAVINESS | 5 0.05 86.91 SENSORY DISTURBANCE | 9 0.09 87.00 SENSORY LOSS | 2 0.02 87.02 SEPSIS | 22 0.22 87.24 SEPSIS NEONATAL | 1 0.01 87.25 SEPTIC SHOCK | 13 0.13 87.38 SEQUESTRECTOMY | 2 0.02 87.40 SEROSITIS | 1 0.01 87.41 SEROTONIN SYNDROME | 3 0.03 87.44 SERUM FERRITIN INCREASED | 3 0.03 87.47 SEXUAL DYSFUNCTION | 3 0.03 87.50 SHOCK | 7 0.07 87.57 SHUNT OCCLUSION | 1 0.01 87.58 SICKLE CELL ANAEMIA WITH CRISIS | 1 0.01 87.59 SINUS ARRHYTHMIA | 1 0.01 87.60 SINUS BRADYCARDIA | 2 0.02 87.62 SINUS CONGESTION | 2 0.02 87.64 SINUS DISORDER | 2 0.02 87.66 SINUS HEADACHE | 2 0.02 87.68 SINUS OPERATION | 1 0.01 87.69 SINUS TACHYCARDIA | 9 0.09 87.78 SINUSITIS | 13 0.13 87.91 SKIN ATROPHY | 1 0.01 87.92 SKIN BURNING SENSATION | 2 0.02 87.94 SKIN CANCER | 1 0.01 87.95 SKIN CHAPPED | 1 0.01 87.96 SKIN DISCOLOURATION | 5 0.05 88.01 SKIN DISORDER | 3 0.03 88.04 SKIN EXFOLIATION | 12 0.12 88.16 SKIN HAEMORRHAGE | 2 0.02 88.18 SKIN INJURY | 1 0.01 88.19 SKIN LACERATION | 3 0.03 88.22 SKIN LESION | 1 0.01 88.23 SKIN NECROSIS | 3 0.03 88.26 SKIN NEOPLASM EXCISION | 1 0.01 88.27 SKIN ODOUR ABNORMAL | 2 0.02 88.29 SKIN OEDEMA | 2 0.02 88.31 SKIN REACTION | 1 0.01 88.32 SKIN TEST POSITIVE | 1 0.01 88.33 SKIN TIGHTNESS | 1 0.01 88.34 SKIN ULCER | 4 0.04 88.38 SKIN WRINKLING | 1 0.01 88.39 SLEEP APNOEA SYNDROME | 5 0.05 88.44 SLEEP DISORDER | 8 0.08 88.52 SLEEP TERROR | 1 0.01 88.53 SLEEP WALKING | 2 0.02 88.55 SLUGGISHNESS | 1 0.01 88.56 SMALL CELL LUNG CANCER METASTATIC | 1 0.01 88.57 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 1 0.01 88.58 SMALL FOR DATES BABY | 2 0.02 88.60 SMALL INTESTINAL OBSTRUCTION | 3 0.03 88.63 SMALL INTESTINE CARCINOMA | 1 0.01 88.64 SMOOTH MUSCLE ANTIBODY POSITIVE | 1 0.01 88.65 SNEEZING | 3 0.03 88.68 SNORING | 1 0.01 88.69 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 88.70 SOFT TISSUE DISORDER | 2 0.02 88.72 SOFT TISSUE INFLAMMATION | 1 0.01 88.73 SOFT TISSUE NECROSIS | 1 0.01 88.74 SOLAR ELASTOSIS | 1 0.01 88.75 SOMATIC DELUSION | 1 0.01 88.76 SOMNOLENCE | 34 0.34 89.10 SOMNOLENCE NEONATAL | 3 0.03 89.13 SPEECH DISORDER | 17 0.17 89.30 SPERMATOZOA PROGRESSIVE MOTILITY DECR.. | 1 0.01 89.31 SPINAL COLUMN STENOSIS | 1 0.01 89.32 SPINAL COMPRESSION FRACTURE | 2 0.02 89.34 SPINAL CORD INFARCTION | 1 0.01 89.35 SPINAL CORD OPERATION | 1 0.01 89.36 SPINAL DISORDER | 3 0.03 89.39 SPINAL FRACTURE | 1 0.01 89.40 SPINAL FUSION SURGERY | 1 0.01 89.41 SPINAL LAMINECTOMY | 1 0.01 89.42 SPINAL OSTEOARTHRITIS | 1 0.01 89.43 SPLEEN DISORDER | 1 0.01 89.44 SPLENIC INFARCTION | 2 0.02 89.46 SPLENIC RUPTURE | 1 0.01 89.47 SPLENOMEGALY | 5 0.05 89.52 SPONDYLOLISTHESIS | 1 0.01 89.53 SPUTUM ABNORMAL | 1 0.01 89.54 SPUTUM CULTURE POSITIVE | 2 0.02 89.56 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 89.57 STAPHYLOCOCCAL INFECTION | 10 0.10 89.67 STAPHYLOCOCCAL SEPSIS | 5 0.05 89.72 STARING | 1 0.01 89.73 STATUS EPILEPTICUS | 3 0.03 89.76 STEM CELL TRANSPLANT | 2 0.02 89.78 STENT OCCLUSION | 1 0.01 89.79 STENT PLACEMENT | 4 0.04 89.83 STEREOTYPIC MOVEMENT DISORDER | 1 0.01 89.84 STEVENS-JOHNSON SYNDROME | 17 0.17 90.01 STOMACH DISCOMFORT | 3 0.03 90.04 STOMATITIS | 7 0.07 90.11 STREPTOCOCCAL INFECTION | 4 0.04 90.15 STRESS | 5 0.05 90.20 STRIDOR | 5 0.05 90.25 SUBARACHNOID HAEMORRHAGE | 8 0.08 90.33 SUBCUTANEOUS EMPHYSEMA | 4 0.04 90.37 SUBDURAL HAEMATOMA | 2 0.02 90.39 SUBDURAL HAEMORRHAGE | 2 0.02 90.41 SUBILEUS | 2 0.02 90.43 SUBSTANCE ABUSE | 2 0.02 90.45 SUDDEN CARDIAC DEATH | 1 0.01 90.46 SUDDEN DEATH | 9 0.09 90.55 SUFFOCATION FEELING | 1 0.01 90.56 SUICIDAL BEHAVIOUR | 2 0.02 90.58 SUICIDAL IDEATION | 21 0.21 90.79 SUICIDE ATTEMPT | 20 0.20 90.99 SULPHAEMOGLOBIN INCREASED | 1 0.01 91.00 SUNBURN | 1 0.01 91.01 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 91.02 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 91.03 SURGERY | 6 0.06 91.09 SURGICAL PROCEDURE REPEATED | 2 0.02 91.11 SWELLING | 7 0.07 91.18 SWELLING FACE | 11 0.11 91.29 SWOLLEN TONGUE | 5 0.05 91.34 SYNCOPE | 21 0.21 91.55 SYNCOPE VASOVAGAL | 1 0.01 91.56 SYNDACTYLY | 1 0.01 91.57 SYNOVIAL CYST | 1 0.01 91.58 SYNOVITIS | 1 0.01 91.59 SYSTEMIC CANDIDA | 1 0.01 91.60 SYSTEMIC LUPUS ERYTHEMATOSUS | 3 0.03 91.63 SYSTEMIC MYCOSIS | 1 0.01 91.64 T-CELL LYMPHOMA | 2 0.02 91.66 TACHYARRHYTHMIA | 1 0.01 91.67 TACHYCARDIA | 25 0.25 91.92 TACHYPNOEA | 4 0.04 91.96 TARDIVE DYSKINESIA | 1 0.01 91.97 TEARFULNESS | 1 0.01 91.98 TEMPERATURE INTOLERANCE | 3 0.03 92.01 TENDERNESS | 2 0.02 92.03 TENDON DISORDER | 2 0.02 92.05 TENDON RUPTURE | 1 0.01 92.06 TENDONITIS | 3 0.03 92.09 TENOSYNOVITIS | 1 0.01 92.10 TENSION | 1 0.01 92.11 TERMINAL STATE | 1 0.01 92.12 TESTICULAR PAIN | 1 0.01 92.13 TESTICULAR SWELLING | 1 0.01 92.14 THEFT | 1 0.01 92.15 THERAPEUTIC AGENT TOXICITY | 4 0.04 92.19 THERAPEUTIC PRODUCT CONTAMINATION | 1 0.01 92.20 THERAPEUTIC RESPONSE DECREASED | 11 0.11 92.31 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 7 0.07 92.38 THERAPY NON-RESPONDER | 11 0.11 92.49 THERMAL BURN | 1 0.01 92.50 THINKING ABNORMAL | 7 0.07 92.57 THIRST | 1 0.01 92.58 THOUGHT BLOCKING | 1 0.01 92.59 THROAT CANCER | 3 0.03 92.62 THROAT IRRITATION | 5 0.05 92.67 THROAT TIGHTNESS | 7 0.07 92.74 THROMBOCYTHAEMIA | 2 0.02 92.76 THROMBOCYTOPENIA | 32 0.32 93.08 THROMBOCYTOPENIC PURPURA | 1 0.01 93.09 THROMBOPHLEBITIS | 2 0.02 93.11 THROMBOSIS | 21 0.21 93.32 THROMBOTIC MICROANGIOPATHY | 2 0.02 93.34 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 93.35 THYROID CANCER | 1 0.01 93.36 THYROID CYST | 1 0.01 93.37 THYROID DISORDER | 1 0.01 93.38 THYROID MASS | 1 0.01 93.39 THYROID NEOPLASM | 1 0.01 93.40 THYROXINE FREE ABNORMAL | 1 0.01 93.41 TIC | 1 0.01 93.42 TINNITUS | 7 0.07 93.49 TOE AMPUTATION | 3 0.03 93.52 TONGUE DISCOLOURATION | 2 0.02 93.54 TONGUE DISORDER | 3 0.03 93.57 TONSILLITIS | 1 0.01 93.58 TOOTH ABSCESS | 3 0.03 93.61 TOOTH DEVELOPMENT DISORDER | 1 0.01 93.62 TOOTH DISCOLOURATION | 2 0.02 93.64 TOOTH DISORDER | 4 0.04 93.68 TOOTH EXTRACTION | 13 0.13 93.81 TOOTH FRACTURE | 1 0.01 93.82 TOOTH INFECTION | 3 0.03 93.85 TOOTH INJURY | 1 0.01 93.86 TOOTH LOSS | 4 0.04 93.90 TOOTHACHE | 2 0.02 93.92 TOXIC EPIDERMAL NECROLYSIS | 10 0.10 94.02 TOXIC INDUCED ENCEPHALOPATHY | 2 0.02 94.04 TOXICOLOGIC TEST ABNORMAL | 1 0.01 94.05 TOXOPLASMOSIS | 1 0.01 94.06 TRACHEAL HAEMORRHAGE | 1 0.01 94.07 TRANSAMINASES INCREASED | 10 0.10 94.17 TRANSFUSION | 1 0.01 94.18 TRANSIENT ISCHAEMIC ATTACK | 9 0.09 94.27 TRANSIENT PSYCHOSIS | 1 0.01 94.28 TRANSMISSION OF DRUG VIA SEMEN | 1 0.01 94.29 TRANSPLANT | 1 0.01 94.30 TRANSPLANT REJECTION | 1 0.01 94.31 TREATMENT NONCOMPLIANCE | 17 0.17 94.48 TREATMENT RELATED SECONDARY MALIGNANCY | 1 0.01 94.49 TREMOR | 27 0.27 94.76 TRICUSPID VALVE INCOMPETENCE | 1 0.01 94.77 TRIGEMINAL NEURALGIA | 1 0.01 94.78 TRISMUS | 1 0.01 94.79 TRISOMY 21 | 1 0.01 94.80 TRISOMY 8 | 1 0.01 94.81 TUBERCULOSIS | 5 0.05 94.86 TUBULOINTERSTITIAL NEPHRITIS | 3 0.03 94.89 TUMOUR ASSOCIATED FEVER | 2 0.02 94.91 TUMOUR EXCISION | 1 0.01 94.92 TUMOUR HAEMORRHAGE | 1 0.01 94.93 TUMOUR LYSIS SYNDROME | 1 0.01 94.94 TUMOUR NECROSIS | 1 0.01 94.95 TUMOUR PERFORATION | 1 0.01 94.96 TUNNEL VISION | 2 0.02 94.98 TYPE IV HYPERSENSITIVITY REACTION | 1 0.01 94.99 ULCER | 2 0.02 95.01 ULCER HAEMORRHAGE | 1 0.01 95.02 ULTRASOUND ANTENATAL SCREEN ABNORMAL | 1 0.01 95.03 ULTRASOUND KIDNEY ABNORMAL | 1 0.01 95.04 UMBILICAL CORD ABNORMALITY | 1 0.01 95.05 UMBILICAL HERNIA | 2 0.02 95.07 UNDERDOSE | 3 0.03 95.10 UNEMPLOYMENT | 1 0.01 95.11 UNEVALUABLE EVENT | 9 0.09 95.20 UNRESPONSIVE TO STIMULI | 2 0.02 95.22 UNWANTED AWARENESS DURING ANAESTHESIA | 1 0.01 95.23 UPPER EXTREMITY MASS | 1 0.01 95.24 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 95.26 UPPER LIMB FRACTURE | 2 0.02 95.28 UPPER RESPIRATORY FUNGAL INFECTION | 1 0.01 95.29 UPPER RESPIRATORY TRACT INFECTION | 3 0.03 95.32 UPPER RESPIRATORY TRACT INFLAMMATION | 1 0.01 95.33 URETHRAL OBSTRUCTION | 1 0.01 95.34 URINARY INCONTINENCE | 6 0.06 95.40 URINARY RETENTION | 7 0.07 95.47 URINARY SEDIMENT PRESENT | 1 0.01 95.48 URINARY TRACT DISORDER | 1 0.01 95.49 URINARY TRACT INFECTION | 16 0.16 95.65 URINARY TRACT INFECTION STAPHYLOCOCCAL | 1 0.01 95.66 URINARY TRACT INFLAMMATION | 1 0.01 95.67 URINE ABNORMALITY | 2 0.02 95.69 URINE AMYLASE INCREASED | 1 0.01 95.70 URINE ANALYSIS ABNORMAL | 1 0.01 95.71 URINE COLOUR ABNORMAL | 3 0.03 95.74 URINE ODOUR ABNORMAL | 1 0.01 95.75 URINE OSMOLARITY DECREASED | 1 0.01 95.76 URINE OUTPUT DECREASED | 2 0.02 95.78 URINE OUTPUT INCREASED | 3 0.03 95.81 URINE SODIUM ABNORMAL | 1 0.01 95.82 URINE SODIUM DECREASED | 1 0.01 95.83 URINE SODIUM INCREASED | 1 0.01 95.84 UROBILIN URINE PRESENT | 1 0.01 95.85 UROGENITAL HAEMORRHAGE | 1 0.01 95.86 UROSEPSIS | 1 0.01 95.87 URTICARIA | 24 0.24 96.11 URTICARIA GENERALISED | 2 0.02 96.13 UTERINE HAEMORRHAGE | 1 0.01 96.14 UTERINE LEIOMYOMA | 1 0.01 96.15 UTERINE POLYP | 1 0.01 96.16 UTEROVAGINAL PROLAPSE | 1 0.01 96.17 UVEITIS | 4 0.04 96.21 VAGINAL BURNING SENSATION | 1 0.01 96.22 VAGINAL FISTULA | 1 0.01 96.23 VAGINAL HAEMORRHAGE | 3 0.03 96.26 VARICELLA | 1 0.01 96.27 VASCULAR BYPASS GRAFT | 1 0.01 96.28 VASCULAR DEMENTIA | 1 0.01 96.29 VASCULAR INSUFFICIENCY | 1 0.01 96.30 VASCULAR PURPURA | 1 0.01 96.31 VASCULITIS | 7 0.07 96.38 VASODILATATION | 1 0.01 96.39 VEIN DISORDER | 1 0.01 96.40 VENA CAVA THROMBOSIS | 1 0.01 96.41 VENOUS INSUFFICIENCY | 1 0.01 96.42 VENTRICULAR ARRHYTHMIA | 1 0.01 96.43 VENTRICULAR DYSFUNCTION | 6 0.06 96.49 VENTRICULAR EXTRASYSTOLES | 6 0.06 96.55 VENTRICULAR FIBRILLATION | 2 0.02 96.57 VENTRICULAR HYPERTROPHY | 3 0.03 96.60 VENTRICULAR HYPOKINESIA | 2 0.02 96.62 VENTRICULAR SEPTAL DEFECT | 1 0.01 96.63 VENTRICULAR TACHYCARDIA | 5 0.05 96.68 VERBAL ABUSE | 1 0.01 96.69 VERTIGO | 18 0.18 96.87 VESTIBULAR NEURONITIS | 1 0.01 96.88 VIRAEMIA | 1 0.01 96.89 VIRAL INFECTION | 4 0.04 96.93 VIRAL LOAD INCREASED | 1 0.01 96.94 VIRAL MUTATION IDENTIFIED | 2 0.02 96.96 VIRAL MYOCARDITIS | 1 0.01 96.97 VIRAL UPPER RESPIRATORY TRACT INFECTION | 1 0.01 96.98 VISION BLURRED | 30 0.30 97.28 VISUAL ACUITY REDUCED | 8 0.08 97.36 VISUAL DISTURBANCE | 18 0.18 97.54 VISUAL FIELD DEFECT | 2 0.02 97.56 VISUAL PATHWAY DISORDER | 1 0.01 97.57 VITAL CAPACITY DECREASED | 1 0.01 97.58 VITAMIN B12 DEFICIENCY | 2 0.02 97.60 VITAMIN K INCREASED | 1 0.01 97.61 VITRECTOMY | 1 0.01 97.62 VITREOUS DEGENERATION | 1 0.01 97.63 VITREOUS DETACHMENT | 1 0.01 97.64 VITREOUS FLOATERS | 3 0.03 97.67 VITREOUS HAEMORRHAGE | 3 0.03 97.70 VOCAL CORD DISORDER | 1 0.01 97.71 VOCAL CORD THICKENING | 1 0.01 97.72 VOLVULUS | 1 0.01 97.73 VOMITING | 75 0.75 98.48 VOMITING PROJECTILE | 1 0.01 98.49 VULVOVAGINAL DRYNESS | 1 0.01 98.50 WALKING AID USER | 1 0.01 98.51 WEIGHT DECREASED | 25 0.25 98.76 WEIGHT FLUCTUATION | 1 0.01 98.77 WEIGHT GAIN POOR | 1 0.01 98.78 WEIGHT INCREASED | 25 0.25 99.03 WEST NILE VIRAL INFECTION | 1 0.01 99.04 WHEEZING | 9 0.09 99.13 WHIPLASH INJURY | 1 0.01 99.14 WHITE BLOOD CELL COUNT ABNORMAL | 2 0.02 99.16 WHITE BLOOD CELL COUNT DECREASED | 26 0.26 99.42 WHITE BLOOD CELL COUNT INCREASED | 19 0.19 99.61 WHITE BLOOD CELLS URINE POSITIVE | 1 0.01 99.62 WOLFF-PARKINSON-WHITE SYNDROME | 1 0.01 99.63 WOUND CLOSURE | 1 0.01 99.64 WOUND COMPLICATION | 2 0.02 99.66 WOUND DEBRIDEMENT | 1 0.01 99.67 WOUND DEHISCENCE | 2 0.02 99.69 WOUND DRAINAGE | 1 0.01 99.70 WOUND INFECTION PSEUDOMONAS | 1 0.01 99.71 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.72 WRIST FRACTURE | 1 0.01 99.73 WRONG DRUG ADMINISTERED | 14 0.14 99.87 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 5 0.05 99.92 X-RAY ABNORMAL | 1 0.01 99.93 XEROPHTHALMIA | 1 0.01 99.94 XEROSIS | 1 0.01 99.95 YAWNING | 1 0.01 99.96 YELLOW SKIN | 3 0.03 99.99 YERSINIA INFECTION | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015